Publications scientifiques des membres de la filière
Vous retrouverez ci-dessous les publications scientifiques des membres de la filière Filfoie. Elles sont organisées par type de pathologie et par année :
Atrésie des Voies Biliaires et Cholestases Génétiques
Nomden M, Alizai NK, Betalli P, Bruggink JLM, Cananzi M, Christensen VB, D’Antiga L, Davenport M, Fischler B, Hindemith L, Hukkinen M, Johansen LS, de Kleine RH, Madadi-Sanjani O, Ong EGP, Pakarinen MP, Petersen C, Ruiz M, Schunn M, Sturm E, Verkade HJ, Wildhaber BE, Hulscher JBF, On Behalf Of Members Of The Biliary Atresia And Related Disorders Bard Community The Ern RARE-Liver. Incidence of Isolated Biliary Atresia during the COVID Lockdown in Europe: Results from a Collaborative Project by RARE-Liver. J Clin Med. 2023 Jan 18;12(3):775. doi: 10.3390/jcm12030775.
PMID: 36769422
Guillaud O, Dumortier J, Couchonnal-Bedoya E, Ruiz M. Wilson Disease and Alpha1-Antitrypsin Deficiency: A Review of Non-Invasive Diagnostic Tests. Diagnostics (Basel). 2023 Jan 10;13(2):256. doi: 10.3390/diagnostics13020256.
PMID: 36673066
Felzen A, van Wessel DBE, Gonzales E, Thompson RJ, Jankowska I, Shneider BL, Sokal E, Grammatikopoulos T, Kadaristiana A, Jacquemin E, Spraul A, Lipiński P, Czubkowski P, Rock N, Shagrani M, Broering D, Nicastro E, Kelly D, Nebbia G, Arnell H, Fischler B, Hulscher JBF, Serranti D, Arikan C, Polat E, Debray D, Lacaille F, Goncalves C, Hierro L, Muñoz Bartolo G, Mozer-Glassberg Y, Azaz A, Brecelj J, Dezsőfi A, Calvo PL, Grabhorn E, Hartleif S, van der Woerd WJ, Kamath BM, Wang JS, Li L, Durmaz Ö, Kerkar N, Jørgensen MH, Fischer R, Jimenez-Rivera C, Alam S, Cananzi M, Laverdure N, Ferreira CT, Guerrero FO, Wang H, Sency V, Kim KM, Chen HL, de Carvalho E, Fabre A, Bernabeu JQ, Zellos A, Alonso EM, Sokol RJ, Suchy FJ, Loomes KM, McKiernan PJ, Rosenthal P, Turmelle Y, Horslen S, Schwarz K, Bezerra JA, Wang K, Hansen BE, Verkade HJ; NAtural course and Prognosis of PFIC and Effect of biliary Diversion (NAPPED) Consortium. Genotype-phenotype relationships of truncating mutations, p.E297G and p.D482G in bile salt export pump deficiency. JHEP Rep. 2022 Nov 16;5(2):100626. doi: 10.1016/j.jhepr.2022.100626. eCollection 2023 Feb.
PMID: 36687469
Ruiz M, Lacaille F, Schrader C, Pons M, Socha P, Krag A, Sturm E, Bouchecareilh M, Strnad P. Pediatric and adult liver disease in alpha1-antitrypsin deficiency.
Semin Liver Dis. 2023 Jul 4. doi: 10.1055/a-2122-7674. Online ahead of print.
PMID: 37402396
Sokol RJ, Gonzales EM, Kamath BM, Baker A, Vig P, Mogul DB, Garner W, Hansen BE, Jacquemin E, Thompson RJ. Predictors of 6-year event-free survival in alagille syndrome patients treated with maralixibat, an ileal bile acid transporter inhibitor.
Hepatology. 2023 Jun 7. doi: 10.1097/HEP.0000000000000502. Online ahead of print.
PMID: 37278241
Wischlen E, Laverdure N, Erard D, Rohmer B, Boillot O, Dubois R, Lachaux A, Collardeau-Frachon S, Hervieu V, Dumortier J. Iterative antibody-induced bile salt export pump deficiency after successive liver transplantations successfully treated with plasmapheresis and rituximab.
Clin Res Hepatol Gastroenterol. 2023 May;47(6):102139. doi: 10.1016/j.clinre.2023.102139. Epub 2023 May 13.
PMID: 37187258
Dana J, Debray D, Vilgrain V. Reply to: « The effects of CFTR modulator therapies on liver stiffness and bile flow: A single centre experience ».
J Hepatol. 2023 Apr 10:S0168-8278(23)00222-2. doi: 10.1016/j.jhep.2023.04.001. Online ahead of print.
PMID: 37044220
Fuchs J, Mrad C, Gonzales E, Ndiaye D, Fouquet V, Héry G, Baujard C, Guérin F, Branchereau S. Biliary drainage surgery before or after 3 months of life versus primary liver transplantation in children with biliary atresia: comparative cohort study.
BJS Open. 2023 Mar 7;7(2):zrac175. doi: 10.1093/bjsopen/zrac175.
PMID: 36952250
Bahadori A, Kuhlmann B, Debray D, Franchi-Abella S, Wacker J, Beghetti M, Wildhaber BE, McLin VA, On Behalf Of The Ircpss. Presentation of Congenital Portosystemic Shunts in Children. Children (Basel). 2022 Feb 11;9(2):243. doi: 10.3390/children9020243.
PMID: 35204963
Almes M, Spraul A, Ruiz M, Girard M, Roquelaure B, Laborde N, Gottrand F, Turquet A, Lamireau T, Dabadie A, Bonneton M, Thebaut A, Rohmer B, Lacaille F, Broué P, Fabre A, Mention-Mulliez K, Bouligand J, Jacquemin E, Gonzales E. Targeted-Capture Next-Generation Sequencing in Diagnosis Approach of Pediatric Cholestasis. Diagnostics (Basel). 2022 May 7;12(5):1169. doi: 10.3390/diagnostics12051169.
PMID : 35626323
Loomes KM, Squires RH, Kelly D, Rajwal S, Soufi N, Lachaux A, Jankowska I, Mack C, Setchell KDR, Karthikeyan P, Kennedy C, Dorenbaum A, Desai NK, Garner W, Jaecklin T, Vig P, Miethke A, Thompson RJ. Maralixibat for the treatment of PFIC: Long-term, IBAT inhibition in an open-label, Phase 2 study. Hepatol Commun. 2022 May 4. doi: 10.1002/hep4.1980. Online ahead of print.
PMID : 35507739
Tran LC, Ley D, Bourdon G, Coopman S, Lerisson H, Tillaux C, Béhal H, Gottrand F, Aumar M. Noninvasive Pediatric Liver Fibrosis Measurement: Two-Dimensional Shear Wave Elastography Compared With Transient Elastography. Front Pediatr. 2022 Apr 28;10:849815. doi: 10.3389/fped.2022.849815. eCollection 2022.
PMID : 35573968
Mornex JF, Balduyck M, Bouchecareilh M, Cuvelier A, Epaud R, Kerjouan M, Le Rouzic O, Pison C, Plantier L, Pujazon MC, Reynaud-Gaubert M, Toutain A, Trumbic B, Willemin MC, Zysman M, Brun O, Campana M, Chabot F, Chamouard V, Dechomet M, Fauve J, Girerd B, Gnakamene C, Lefrançois S, Lombard JN, Maitre B, Maynié-François C, Moerman A, Payancé A, Reix P, Revel D, Revel MP, Schuers M, Terrioux P, Theron D, Willersinn F, Cottin V, Mal H. [French clinical practice guidelines for the diagnosis and management of lung disease with alpha 1-antitrypsin deficiency]. Rev Mal Respir. 2022 Sep;39(7):633-656. doi: 10.1016/j.rmr.2022.06.002. Epub 2022 Jul 27.
PMID: 35906149
Kamath BM, Goldstein A, Howard R, Garner W, Vig P, Marden JR, Billmyer E, Anderson A, Kirson N, Jacquemin E, Gonzales E. Maralixibat treatment response in Alagille syndrome is associated with improved health-related quality of life. J Pediatr. 2022 Sep 10:S0022-3476(22)00791-0. doi: 10.1016/j.jpeds.2022.09.001. Online ahead of print.
PMID: 36096175
Thompson RJ, Arnell H, Artan R, Baumann U, Calvo PL, Czubkowski P, Dalgic B, D’Antiga L, Durmaz Ö, Fischler B, Gonzalès E, Grammatikopoulos T, Gupte G, Hardikar W, Houwen RHJ, Kamath BM, Karpen SJ, Kjems L, Lacaille F, Lachaux A, Lainka E, Mack CL, Mattsson JP, McKiernan P, Özen H, Rajwal SR, Roquelaure B, Shagrani M, Shteyer E, Soufi N, Sturm E, Tessier ME, Verkade HJ, Horn P. Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial. Lancet Gastroenterol Hepatol. 2022 Sep;7(9):830-842. doi: 10.1016/S2468-1253(22)00093-0. Epub 2022 Jul 1.
PMID: 35780807
Privat E, Aumar M, Ley D, Tran LC, Coopman S, Guimber D, Turck D, Gottrand F. Efficacy and tolerance of enteral nutrition in children with biliary atresia awaiting liver transplantation. Front Pediatr. 2022 Sep 2;10:983717. doi: 10.3389/fped.2022.983717. eCollection 2022.
PMID: 36120654
Vandriel SM, Li LT, She H, Wang JS, Gilbert MA, Jankowska I, Czubkowski P, Gliwicz-Miedzińska D, Gonzales EM, Jacquemin E, Bouligand J, Spinner NB, Loomes KM, Piccoli DA, D’Antiga L, Nicastro E, Sokal É, Demaret T, Ebel NH, Feinstein JA, Fawaz R, Nastasio S, Lacaille F, Debray D, Arnell H, Fischler B, Siew S, Stormon M, Karpen SJ, Romero R, Kim KM, Baek WY, Hardikar W, Shankar S, Roberts AJ, Evans HM, Jensen MK, Kavan M, Sundaram SS, Chaidez A, Karthikeyan P, Sanchez MC, Cavalieri ML, Verkade HJ, Lee WS, Squires JE, Hajinicolaou C, Lertudomphonwanit C, Fischer RT, Larson-Nath C, Mozer-Glassberg Y, Arikan C, Lin HC, Bernabeu JQ, Alam S, Kelly DA, Carvalho E, Ferreira CT, Indolfi G, Quiros-Tejeira RE, Bulut P, Calvo PL, Önal Z, Valentino PL, Desai DM, Eshun J, Rogalidou M, Dezsőfi A, Wiecek S, Nebbia G, Pinto RB, Wolters VM, Tamara ML, Zizzo AN, Garcia J, Schwarz K, Beretta M, Sandahl TD, Jimenez-Rivera C, Kerkar N, Brecelj J, Mujawar Q, Rock N, Busoms CM, Karnsakul W, Lurz E, Santos-Silva E, Blondet N, Bujanda L, Shah U, Thompson RJ, Hansen BE, Kamath BM; Global ALagille Alliance (GALA) Study Group. Natural history of liver disease in a large international cohort of children with Alagille syndrome: Results from the GALA study. Hepatology. 2022 Aug 29. doi: 10.1002/hep.32761. Online ahead of print.
PMID: 36036223
van Wessel DBE, Gonzales E, Hansen BE, Verkade HJ. Defining the natural history of rare genetic liver diseases: Lessons learned from the NAPPED initiative. Eur J Med Genet. 2021 May 13;64(7):104245.
PMID: 33991701
Joly P, Ruiz M, Garin R, Karatas E, Lachaux A, Restier L, Belmalih A, Renoux C, Lombard C, Dechomet M, Bouchecareilh M. A Particular SORL1 Micro-Haplotype May Prevent from Severe Liver Disease in a French Cohort of Alpha 1-Antitrypsin Deficiency Children. J Pediatr Gastroenterol Nutr. 2021 Mar 12.
PMID: 33720088
van Wessel DBE, Thompson RJ, Gonzales E, Jankowska I, Shneider BL, Sokal E, Grammatikopoulos T, Kadaristiana A, Jacquemin E, Spraul A, Lipiński P, Czubkowski P, Rock N, Shagrani M, Broering D, Algoufi T, Mazhar N, Nicastro E, Kelly D, Nebbia G, Arnell H, Fischler B, Hulscher JBF, Serranti D, Arikan C, Debray D, Lacaille F, Goncalves C, Hierro L, Muñoz Bartolo G, Mozer-Glassberg Y, Azaz A, Brecelj J, Dezsőfi A, Luigi Calvo P, Krebs-Schmitt D, Hartleif S, van der Woerd WL, Wang JS, Li LT, Durmaz Ö, Kerkar N, Hørby Jørgensen M, Fischer R, Jimenez-Rivera C, Alam S, Cananzi M, Laverdure N, Ferreira CT, Ordonez F, Wang H, Sency V, Kim KM, Chen HL, Carvalho E, Fabre A, Quintero Bernabeu J, Alonso EM, Sokol RJ, Suchy FJ, Loomes KM, McKiernan PJ, Rosenthal P, Turmelle Y, Rao GS, Horslen S, Kamath BM, Rogalidou M, Karnsakul WW, Hansen B, Verkade HJ. Impact of Genotype, Serum Bile Acids, and Surgical Biliary Diversion on Native Liver Survival in FIC1 Deficiency. Hepatology. 2021 Mar 5.
PMID: 33666275
Joly P, Ruiz M, Garin R, Karatas E, Lachaux A, Restier L, Belmalih A, Renoux C, Lombard C, Dechomet M, Bouchecareilh M. A Particular SORL1 Micro-haplotype May Prevent Severe Liver Disease in a French Cohort of Alpha 1-Antitrypsin-deficient Children. J Pediatr Gastroenterol Nutr. 2021 Sep 1;73(3):e68-e72. doi: 10.1097/MPG.0000000000003125.
PMID: 33720088
Baumann U, Sturm E, Lacaille F, Gonzalès E, Arnell H, Fischler B, Jørgensen MH, Thompson RJ, Mattsson JP, Ekelund M, Lindström E, Gillberg PG, Torfgård K, Soni PN. Effects of odevixibat on pruritus and bile acids in children with cholestatic liver disease: Phase 2 study. Clin Res Hepatol Gastroenterol. 2021 Jun 26;45(5):101751. doi: 10.1016/j.clinre.2021.101751. Online ahead of print.
PMID: 34182185
Gonzales E, Hardikar W, Stormon M, Baker A, Hierro L, Gliwicz D, Lacaille F, Lachaux A, Sturm E, Setchell KDR, Kennedy C, Dorenbaum A, Steinmetz J, Desai NK, Wardle AJ, Garner W, Vig P, Jaecklin T, Sokal EM, Jacquemin E. Efficacy and safety of maralixibat treatment in patients with Alagille syndrome and cholestatic pruritus (ICONIC): a randomised phase 2 study. Lancet. 2021 Oct 30;398(10311):1581-1592. doi: 10.1016/S0140-6736(21)01256-3. Epub 2021 Oct 28.
PMID: 34755627
Karatas E, Bouchecareilh M. Alpha 1-Antitrypsin Deficiency: A Disorder of Proteostasis-Mediated Protein Folding and Trafficking Pathways. Int J Mol Sci. 2020 Feb 21;21(4). pii: E1493. doi: 10.3390
PMID: 32098273
van Wessel DBE, Thompson RJ, Gonzales E, Jankowska I, Sokal E, Grammatikopoulos T, Kadaristiana A, Jacquemin E, Spraul A, Lipiński P, Czubkowski P, Rock N, Shagrani M, Broering D, Algoufi T, Mazhar N, Nicastro E, Kelly D, Nebbia G, Arnell H, Fischler BR, Hulscher JBF, Serranti D, Arikan C, Polat E, Debray D, Lacaille F, Goncalves C, Hierro L, Muñoz Bartolo G, Mozer-Glassberg Y, Azaz A, Brecelj J, Dezsőfi A, Calvo PL, Grabhorn E, Sturm E, van der Woerd WJ, Kamath BM, Wang JS, Li L, Durmaz Ö, Onal Z, Bunt TM, Hansen B, Verkade HJ. Genotype correlates with the natural history of severe bile salt export pump deficiency. J Hepatol. 2020 Feb 19. pii: S0168-8278(20)30105-7. doi: 10.1016
PMID: 32087350
Almes M, Jobert A, Lapalus M, Mareux E, Gonzales E, Jacquemin E. Glycerol Phenylbutyrate Therapy in Progressive Familial Intrahepatic Cholestasis Type 2. J Pediatr Gastroenterol Nutr. 2020 Jun;70(6):e139-e140. doi: 10.1097/MPG.0000000000002713.
PMID: 32443059
Alsafri MS, Charbit-Henrion F, Lacaille F, Bourrat E, Steffann J, Hadj-Rabia S.
Novel CLDN1 Deletion Associated with Ichthyosis, Sclerosing Cholangitis and Acquired Alopecia.
Acta Derm Venereol. 2020 May 19. doi: 10.2340/00015555-3522. Online ahead of print.
PMID: 32424433
Dumortier J, Lachaux A, Collardeau-Frachon S, Valette PJ. Hemorrhagic and necrotic adenoma associated with a congenital portosystemic shunt. Dig Liver Dis. 2020 May 17:S1590-8658(20)30182-1. doi: 10.1016/j.dld.2020.04.026. Online ahead of print.
PMID: 32434737
Pécriaux A, Lewin M, Ciacio O, Jacquemin E, Guettier C. Extrahepatic biliary duplication with heterotopic gastric mucosa in a 46,XX male patient. Clin Res Hepatol Gastroenterol. 2020 Mar 13:S2210-7401(20)30042-5. doi: 10.1016/j.clinre.2020.02.009. Online ahead of print.
PMID: 32179063
Quintero J, Juamperez J, Gonzales E, Julio E, Mercadal-Hally M, Collado-Hilly M, Marín-Sánchez A, Charco R. Successful Treatment with Rituximab and Immunoadsorption for an Auto-Antibody Induced Bile Salt Export Pump Deficiency in a Liver Transplanted Patient. Pediatr Gastroenterol Hepatol Nutr. 2020 Mar;23(2):174-179. doi: 10.5223/pghn.2020.23.2.174. Epub 2020 Mar 4.
PMID: 32206630
Bouchecareilh M. Alpha-1 Antitrypsin Deficiency-Mediated Liver Toxicity: Why Do Some Patients Do Poorly? What Do We Know So Far? Chronic Obstr Pulm Dis. 2020 Jul;7(3):172-181. doi: 10.15326/jcopdf.7.3.2019.0148.
PMID: 32558486
Lykavieris P, Bernard O, Jacquemin E. Ursodeoxycholic acid therapy throughout pregnancy in women affected with chronic cholestasis of childhood: No evidence for teratogenicity. Clin Res Hepatol Gastroenterol. 2020 Jun 18:S2210-7401(20)30165-0. doi: 10.1016/j.clinre.2020.05.020. Online ahead of print.
PMID: 32565202
Lambert V, Ladarre D, Fortas F, Durand P, Hervé P, Gonzales E, Guérin F, Savale L, McLin VA, Ackermann O, Franchi-Abella S; International Registry of Congenital Portosystemic Shunts (IRCPSS). Cardiovascular disorders in patients with congenital portosystemic shunts: 23 years of experience in a tertiary referral centre. Arch Cardiovasc Dis. 2020 Dec 3:S1875-2136(20)30237-0. doi: 10.1016/j.acvd.2020.10.003. Online ahead of print.
PMID: 33281106
Goubran M, Aderibigbe A, Jacquemin E, Guettier C, Girgis S, Bain V, Mason AL. Case report: progressive familial intrahepatic cholestasis type 3 with compound heterozygous ABCB4 variants diagnosed 15 years after liver transplantation. BMC Med Genet. 2020 Nov 30;21(1):238. doi: 10.1186/s12881-020-01173-0.
PMID: 33256620
Guillaud O, Jacquemin E, Couchonnal E, Vanlemmens C, Francoz C, Chouik Y, Conti F, Duvoux C, Hilleret MN, Kamar N, Houssel-Debry P, Neau-Cransac M, Pageaux GP, Gonzales E, Ackermann O, Gugenheim J, Lachaux A, Ruiz M, Radenne S, Debray D, Lacaille F, McLin V, Duclos-Vallée JC, Samuel D, Coilly A, Dumortier J. Long term results of liver transplantation for alpha-1 antitrypsin deficiency. Dig Liver Dis. 2020 Oct 30:S1590-8658(20)30970-1. doi: 10.1016/j.dld.2020.10.016. Online ahead of print.
PMID: 33139195
Karatas E, Bouchecareilh M. Alpha 1-Antitrypsin deficiency in liver explants in a Mexican cohort: A unique cohort to assess the role of heterozygous genotypes in liver disease. Clin Res Hepatol Gastroenterol. 2020 Oct 14:S2210-7401(20)30276-X. doi: 10.1016/j.clinre.2020.09.003. Online ahead of print.
PMID: 33069636
Nicoară-Farcău O, Han G, Rudler M, Angrisani D, Monescillo A, Torres F, Casanovas G, Bosch J, Lv Y, Thabut D, Fan D, Hernández-Gea V, García-Pagán JC; preemptive TIPS individual data metanalysis, International Variceal Bleeding Study and Baveno Cooperation Study groups. Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: a Meta-analysis of Individual Patient Data. Gastroenterology. 2020 Sep 24:S0016-5085(20)35207-0. doi: 10.1053/j.gastro.2020.09.026. Online ahead of print.
PMID: 32980344
McLin VA, Franchi-Abella S, Debray D, Guérin F, Beghetti M, Savale L, Wildhaber BE, Gonzales E; Members of the International Registry of Congenital Porto-Systemic Shunts. Congenital Portosystemic Shunts: Current Diagnosis and Management. J Pediatr Gastroenterol Nutr. 2019 Jan4.
PMID: 30628988
Fanna M, Masson G, Capito C, Girard M, Guerin F, Hermeziu B, Lachaux A, Roquelaure B, Gottrand F, Broue P, Dabadie A, Lamireau T, Jacquemin E, Chardot C. Management of Biliary Atresia in France 1986-2015: Long Term Results. J Pediatr Gastroenterol Nutr. 2019 Jul 22. doi: 10.1097
PMID: 31335841
Vondrak K, Parisi F, Dhawan A, Grenda R, Webb NJ, Marks SD, Debray D, Holt RC, Lachaux A, Kelly D, Kazeem G, Undre N. Efficacy and safety of tacrolimus in de novo pediatric transplant recipients randomized to receive immediate- or prolonged-release tacrolimus. Clin Transplant. 2019 Aug 22. doi: 10.1111/ctr.13698.
PMID: 31436896
Rubik J, Debray D, Kelly D, Iserin F, Webb NJA, Czubkowski P, Vondrak K, Sellier-Leclerc AL, Rivet C, Riva S, Tönshoff B, D’Antiga L, Marks SD, Raymond R, Kazeem G, Undre N. Efficacy and safety of prolonged-release tacrolimus in stable pediatric allograft recipients converted from immediate-release tacrolimus. Transpl Int. 2019 Jul 20. doi: 10.1111/tri.13479.
PMID: 31325368
Ferrara G, Giani T, Lieberman SM, Kremer C, Hong S, Indolfi G, Schulert G, Cron RQ, Mannion ML, Lapidus S, Armbrust W, Gonzales E, Jacquemin E, Koné-Paut I, Cimaz R. Alagille Syndrome and Chronic Arthritis: An International Case Series. J Pediatr. 2019 Nov 17. pii: S0022-3476(19)31394-0. doi: 10.1016
PMID: 31748120
Gonzales E, Davit-Spraul A, Jacquemin E. A Novel CFC1 Mutation in a Family with Heterotaxy and Biliary Atresia Splenic Malformation Syndromes. J Pediatr Gastroenterol Nutr. 2019 Oct 16
PMID: 31633655
Sciveres M, Cirillo F, Jacquemin E, Maggiore G. Diagnostic protocol of neonatal and infantile cholestasis: can it be improved? J Pediatr. 2019 Oct 9. pii: S0022-3476(19)31211-9
PMID: 31606154
Maladies Inflammatoires des Voies Biliaires
Chouik Y, Chazouillères O, Francoz C, De Martin E, Guillaud O, Abergel A, Altieri M, Barbier L, Besch C, Conti F, Corpechot C, Dharancy S, Durand F, Duvoux C, Gugenheim J, Hardwigsen J, Hilleret MN, Houssel-Debry P, Kamar N, Maucort-Boulch D, Minello A, Neau-Cransac M, Pageaux GP, Radenne S, Roux O, Saliba F, Serée O, Samuel D, Vanlemmens C, Woehl-Jaegle ML, Leroy V, Duclos-Vallée JC, Dumortier J. Long-term outcome of liver transplantation for autoimmune hepatitis: a French nationwide study over 30 years. Liver Int. 2023 Feb 24. doi: 10.1111/liv.15552. Online ahead of print.
PMID: 36825353
Maggiore G, Bernard O, Mosca A, Ballot E, Johanet C, Jacquemin E. Long-term outcomes of patients with type 1 or 2 autoimmune hepatitis presenting in childhood. J Hepatol. 2023 Jan 25:S0168-8278(23)00025-9. doi: 10.1016/j.jhep.2023.01.013. Online ahead of print.
PMID: 36708813
Chouik Y, Francoz C, De Martin E, Guillaud O, Abergel A, Altieri M, Barbier L, Besch C, Chazouillères O, Conti F, Corpechot C, Dharancy S, Durand F, Duvoux C, Gugenheim J, Hardwigsen J, Hilleret MN, Houssel-Debry P, Kamar N, Minello A, Neau-Cransac M, Pageaux GP, Radenne S, Roux O, Saliba F, Samuel D, Vanlemmens C, Woehl-Jaegle ML, Leroy V, Duclos-Vallée JC, Dumortier J. Liver transplantation for autoimmune hepatitis: Pre-transplant does not predict the early post-transplant outcome. Liver Int. 2022 Dec 28. doi: 10.1111/liv.15500. Online ahead of print.
PMID: 36577700
Corpechot C, Lemoinne S, Soret PA, Hansen B, Hirschfield G, Gulamhusein A, Montano-Loza AJ, Lytvyak E, Pares A, Olivas I, Eaton JE, Osman KT, Schramm C, Sebode M, Lohse AW, Dalekos G, Gatselis N, Nevens F, Cazzagon N, Zago A, Russo FP, Floreani A, Abbas N, Trivedi P, Thorburn D, Saffioti F, Barkai L, Roccarina D, Calvaruso V, Fichera A, Delamarre A, Sobenko N, Villamil AM, Medina-Morales E, Bonder A, Patwardhan V, Rigamonti C, Carbone M, Invernizzi P, Cristoferi L, van der Meer A, de Veer R, Zigmond E, Yehezkel E, Kremer AE, Deibel A, Bruns T, Große K, Wetten A, Dyson JK, Jones D, Dumortier J, Pageaux GP, de Lédinghen V, Chazouillères O, Carrat F; Global & ERN Rare-Liver PBC Study Groups. Adequate vs. deep response to UDCA in PBC: To what extent and under what conditions is normal ALP level associated with complication-free survival gain?
Hepatology. 2023 Jul 3. doi: 10.1097/HEP.0000000000000529. Online ahead of print.
PMID: 37399238
Maggiore G, Bernard O, Mosca A, Jacquemin E. Liver histology before treatment withdrawal in autoimmune hepatitis: is it time to review the ESPGHAN recommendations?
J Pediatr Gastroenterol Nutr. 2023 Jun 13. doi: 10.1097/MPG.0000000000003857. Online ahead of print.
PMID: 37307301
Andrade RJ, Aithal GP, de Boer YS, Liberal R, Gerbes A, Regev A, Beretta-Piccoli BT, Schramm C, Kleiner DE, De Martin E, Kullak-Ublick GA, Stirnimann G, Devarbhavi H, Vierling JM, Manns MP, Sebode M, Londoño MC, Avigan M, Robles-Diaz M, García-Cortes M, Atallah E, Heneghan M, Chalasani N, Trivedi PJ, Hayashi PH, Taubert R, Fontana RJ, Weber S, Oo YH, Zen Y, Licata A, Lucena MI, Mieli-Vergani G, Vergani D, Björnsson ES; IAIHG and EASL DHILI Consortium. Nomenclature, Diagnosis and Management of Drug-induced Autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report.
J Hepatol. 2023 May 8:S0168-8278(23)00320-3. doi: 10.1016/j.jhep.2023.04.033. Online ahead of print.
PMID: 37164270
Murillo Perez CF, Ioannou S, Hassanally I, Trivedi PJ, Corpechot C, van der Meer AJ, Lammers WJ, Battezzati PM, Lindor KD, Nevens F, Kowdley KV, Bruns T, Cazzagon N, Floreani A, Mason AL, Gulamhusein A, Ponsioen CY, Carbone M, Lleo A, Mayo MJ, Dalekos GN, Gatselis NK, Thorburn D, Verhelst X, Parés A, Londoño MC, Janssen HLA, Invernizzi P, Vuppalanchi R, Hirschfield GM, Hansen BE, Levy C; Global PBC Study Group. Optimizing therapy in primary biliary cholangitis: Alkaline phosphatase at six months identifies one-year non-responders and predicts survival.
Liver Int. 2023 Jul;43(7):1497-1506. doi: 10.1111/liv.15592. Epub 2023 May 8.
PMID: 37157905
Hirschfield GM, Shiffman ML, Gulamhusein A, Kowdley KV, Vierling JM, Levy C, Kremer AE, Zigmond E, Andreone P, Gordon SC, Bowlus CL, Lawitz EJ, Aspinall RJ, Pratt DS, Raikhelson K, Gonzalez-Huezo MS, Heneghan MA, Jeong SH, Ladrón de Guevara AL, Mayo MJ, Dalekos GN, Drenth JPH, Janczewska E, Leggett BA, Nevens F, Vargas V, Zuckerman E, Corpechot C, Fassio E, Hinrichsen H, Invernizzi P, Trivedi PJ, Forman L, Jones DEJ, Ryder SD, Swain MG, Steinberg A, Boudes PF, Choi YJ, McWherter CA; ENHANCE Study Group*. Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study.
Hepatology. 2023 Apr 6. doi: 10.1097/HEP.0000000000000395. Online ahead of print.
PMID: 37386786
Gerussi A, Verda D, Bernasconi DP, Carbone M, Komori A, Abe M, Inao M, Namisaki T, Mochida S, Yoshiji H, Hirschfield G, Lindor K, Pares A, Corpechot C, Cazzagon N, Floreani A, Marzioni M, Alvaro D, Vespasiani-Gentilucci U, Cristoferi L, Valsecchi MG, Muselli M, Hansen BE, Tanaka A, Invernizzi P. Machine learning in primary biliary cholangitis: A novel approach for risk stratification. Liver Int. 2022 Mar;42(3):615-627. doi: 10.1111/liv.15141. Epub 2022 Jan 7.
PMID: 34951722
Dervout C, Boulais N, Barnetche T, Nousbaum JB, Brenaut E, Misery L. Efficacy of Treatments for Cholestatic Pruritus: A Systemic Review and Meta-analysis. Acta Derm Venereol. 2022 Feb 22;102:adv00653. doi: 10.2340/actadv.v102.310.
PMID: 35088869
Duclos-Vallée JC, Debray D, De Martin E, Beux EL, Louvet A. Best practice guidelines for France regarding the diagnosis and management of autoimmune hepatitis. Clin Res Hepatol Gastroenterol. 2022 Jan 30:101871. doi: 10.1016/j.clinre.2022.101871. Online ahead of print.
PMID: 35108657
Pape S, Snijders RJALM, Gevers TJG, Chazouilleres O, Dalekos GN, Hirschfield GM, Lenzi M, Trauner M, Manns MP, Vierling JM, Montano-Loza AJ, Lohse AW, Schramm C, Drenth JPH, Heneghan MA; International Autoimmune Hepatitis Group (IAIHG) collaborators(‡).Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group. J Hepatol. 2022 Jan 20:S0168-8278(22)00012-5. doi: 10.1016/j.jhep.2021.12.041. Online ahead of print.
PMID: 35066089
Soret PA, Chazouillères O, Corpechot C. [Primary biliary cholangitis]. Rev Prat. 2021 Oct;71(8):885-891.
PMID: 35147347
European Association for the Study of the Liver. Electronic address: jhepatology@easloffice.eu; European Association for the Study of the Liver. EASL Clinical Practice Guidelines on Sclerosing Cholangitis. J Hepatol. 2022 May 31:S0168-8278(22)00326-9. doi: 10.1016/j.jhep.2022.05.011. Online ahead of print.
PMID: 35738507
Dumortier J, Valette PJ, Scoazec JY, Boillot O, Hervieu V. Recurrent IgG4 cholangitis after liver transplantation: Back to the future. Dig Liver Dis. 2022 May 3:S1590-8658(22)00256-0. doi: 10.1016/j.dld.2022.04.010. Online ahead of print.
PMID : 35523701
Dumortier J, Conti F, Scoazec JY. Posttransplant immune-mediated cholangiopathies. Curr Opin Gastroenterol. 2022 Mar 1;38(2):98-103. doi: 10.1097/MOG.0000000000000815.
PMID : 35098931
Murillo Perez CF, Gerussi A, Trivedi PJ, Corpechot C, van der Meer AJ, Maria Battezzati P, Lindor KD, Nevens F, Kowdley KV, Bruns T, Cazzagon N, Floreani A, Tanaka A, Ma X, Mason AL, Gulamhusein A, Ponsioen CY, Carbone M, Lleo A, Mayo MJ, Dalekos GN, Gatselis NK, Thorburn D, Verhelst X, Parés A, Janssen HLA, Hirschfield GM, Hansen BE, Invernizzi P, Lammers WJ; GLOBAL PBC Study Group.
Geographical region and clinical outcomes of patients with primary biliary cholangitis from Western Europe. Eur J Gastroenterol Hepatol. 2023 Jan 1;35(1):112-119. doi: 10.1097/MEG.0000000000002464. Epub 2022 Nov 17.
PMID: 36468575
Corpechot C. Noninvasive Evaluation of Fibrosis and Portal Hypertension in Primary Biliary Cholangitis. Clin Liver Dis. 2022 Nov;26(4):681-689. doi: 10.1016/j.cld.2022.06.010.
PMID: 36270723
de Veer RC, Harms MH, Corpechot C, Thorburn D, Invernizzi P, Janssen HLA, Battezzati PM, Nevens F, Lindor KD, Floreani A, Ponsioen CY, Mayo MJ, Parés A, Mason AL, Kowdley KV, Trivedi PJ, Hirschfield GM, Bruns T, Dalekos GN, Gatselis NK, Verhelst X, Lammers WJ, Hansen BE, van Buuren HR, van der Meer AJ; Global PBC Study Group. Liver transplant-free survival according to alkaline phosphatase and GLOBE score in patients with primary biliary cholangitis treated with ursodeoxycholic acid. Aliment Pharmacol Ther. 2022 Nov;56(9):1408-1418. doi: 10.1111/apt.17226. Epub 2022 Sep 22.
PMID: 36138566
Murillo Perez CF, Fisher H, Hiu S, Kareithi D, Adekunle F, Mayne T, Malecha E, Ness E, van der Meer AJ, Lammers WJ, Trivedi PJ, Battezzati PM, Nevens F, Kowdley KV, Bruns T, Cazzagon N, Floreani A, Mason AL, Parés A, Londoño MC, Invernizzi P, Carbone M, Lleo A, Mayo MJ, Dalekos GN, Gatselis NK, Thorburn D, Verhelst X, Gulamhusein A, Janssen HLA, Smith R, Flack S, Mulcahy V, Trauner M, Bowlus CL, Lindor KD, Corpechot C, Jones D, Mells G, Hirschfield GM, Wason J, Hansen BE; GLOBAL PBC Study Group and the members of the UK-PBC Consortium. Greater Transplant-Free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls. Gastroenterology. 2022 Dec;163(6):1630-1642.e3. doi: 10.1053/j.gastro.2022.08.054. Epub 2022 Sep 20.
PMID: 36150526
Efe C, Taşçılar K, Gerussi A, Bolis F, Lammert C, Ebik B, Stättermayer AF, Cengiz M, Gökçe DT, Cristoferi L, Peralta M, Massoumi H, Montes P, Cerda E, Rigamonti C, Yapalı S, Adali G, Çalışkan AR, Balaban Y, Eren F, Eşkazan T, Barutçu S, Lytvyak E, Zazueta GM, Kayhan MA, Heurgue-Berlot A, De Martin E, Yavuz A, Bıyık M, Narro GC, Duman S, Hernandez N, Gatselis NK, Aguirre J, Idilman R, Silva M, Mendizabal M, Atay K, Güzelbulut F, Dhanasekaran R, Montano-Loza AJ, Dalekos GN, Ridruejo E, Invernizzi P, Wahlin S. SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis. J Autoimmun. 2022 Oct;132:102906. doi: 10.1016/j.jaut.2022.102906. Epub 2022 Sep 7.
PMID: 36088883
Biyoukar M, Corpechot C, El Mouhadi S, Chambenois E, Vanderbecq Q, Barbu V, Dong C, Lemoinne S, Tordjman M, Jomaah R, Chazouilleres O, Arrivé L. A BCB4 variant is associated with hepatobiliary MR abnormalities in people with low-phospholipid-associated cholelithiasis syndrome. JHEP Rep. 2022 Sep 21;4(11):100590. doi: 10.1016/j.jhepr.2022.100590. eCollection 2022 Nov.
PMID: 36277956
Cazzagon N, El Mouhadi S, Vanderbecq Q, Ferreira C, Finnegan S, Lemoinne S, Corpechot C, Chazouillères O, Arrivé L. Quantitative magnetic resonance cholangiopancreatography metrics are associated with disease severity and outcomes in people with primary sclerosing cholangitis. JHEP Rep. 2022 Sep 3;4(11):100577. doi: 10.1016/j.jhepr.2022.100577. eCollection 2022 Nov.
PMID: 36277957
Eliasson J, Lo B, Scramm C, Chazouilleres O, Folseraas T, Beuers U, Ytting H. Survey uncovering variations in the management of primary sclerosing cholangitis across Europe. JHEP Rep. 2022 Aug 14;4(11):100553. doi: 10.1016/j.jhepr.2022.100553. eCollection 2022 Nov.
PMID: 36164416
Biron A, Beaugerie L, Chazouillères O, Kirchgesner J. Impact of thiopurines and tumour necrosis factor antagonists on primary sclerosing cholangitis outcomes in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2022 Sep;56(5):857-868. doi: 10.1111/apt.17123. Epub 2022 Jul 4.
PMID: 35789494
Corpechot C, Carrat F, Gaouar F, Chau F, Hirschfield G, Gulamhusein A, Montano-Loza AJ, Lytvyak E, Schramm C, Pares A, Olivas I, Eaton JE, Osman KT, Dalekos G, Gatselis N, Nevens F, Cazzagon N, Zago A, Russo FP, Abbas N, Trivedi P, Thorburn D, Saffioti F, Barkai L, Roccarina D, Calvaruso V, Fichera A, Delamarre A, Medina-Morales E, Bonder A, Patwardhan V, Rigamonti C, Carbone M, Invernizzi P, Cristoferi L, van der Meer A, de Veer R, Zigmond E, Yehezkel E, Kremer AE, Deibel A, Dumortier J, Bruns T, Große K, Pageaux GP, Wetten A, Dyson J, Jones D, Chazouillères O, Hansen B, de Lédinghen V; Global & ERN Rare-Liver PBC Study Groups. Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis. J Hepatol. 2022 Dec;77(6):1545-1553. doi: 10.1016/j.jhep.2022.06.017. Epub 2022 Jun 28.
PMID: 35777587
European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; European Association for the Study of the Liver. EASL Clinical Practice Guidelines on sclerosing cholangitis. J Hepatol. 2022 Sep;77(3):761-806. doi: 10.1016/j.jhep.2022.05.011. Epub 2022 Jun 21.
PMID: 35738507
Cardon A, Conchon S, Renand A. Mechanisms of autoimmune hepatitis. Curr Opin Gastroenterol. 2021 Mar 1;37(2):79-85. doi: 10.1097/MOG.0000000000000704.
PMID: 33315790
De Martin E, Coilly A, Chazouillères O, Roux O, Peron JM, Houssel-Debry P, Artru F, Silvain C, Ollivier-Hourmand I, Duvoux C, Heurgue-Berlot A, Barge S, Ganne-Carrié N, Pageaux GP, Besch C, Bourlière M, Fontaine H, de Ledinghen V, Dumortier J, Conti F, Radenne S, Debette-Gratien M, Goria O, Durand F, Potier P, Di Martino V, Reboux N, Ichai P, Sebagh M, Mathurin P, Agostini H, Samuel D, Duclos-Vallée JC; FILFOIE consortium – France. Early liver transplantation for corticosteroid non-responders in acute severe autoimmune hepatitis: the SURFASA score. J Hepatol. 2021 Jan 24:S0168-8278(21)00041-6. doi: 10.1016/j.jhep.2020.12.033. Online ahead of print.
PMID: 33503489
Murillo Perez CF, Gulamhusein A, Carbone M, Trivedi PJ, van der Meer AJ, Corpechot C, Battezzati PM, Lammers WJ, Cazzagon N, Floreani A, Parés A, Nevens F, Lleo A, Mayo MJ, Kowdley KV, Ponsioen CY, Dalekos GN, Gatselis NK, Thorburn D, Mason AL, Janssen H, Verhelst X, Bruns T, Lindor KD, Chazouillères O, Invernizzi P, Hansen BE, Hirschfield GM; GLOBAL PBC Study Group. Simplified care-pathway selection for nonspecialist practice: the GLOBAL Primary Biliary Cholangitis Study Group Age, Bilirubin, Alkaline phosphatase risk assessment tool. Eur J Gastroenterol Hepatol. 2020 Dec 14. doi: 10.1097/MEG.0000000000002029. Online ahead of print.
PMID: 33323757
Lemoinne S, Cazzagon N, Chazouillères O, Corpechot C, Arrivé L. Letter: the use of magnetic resonance scores (Anali) for risk stratification in PSC. Aliment Pharmacol Ther. 2021 Jun;53(12):1329-1330.
PMID: 34029414
Maggiore G, Pietrobattista A, Liccardo D, Sciveres M, Nastasio S, Jacquemin E, Bernard O. Seronegative Autoimmune Hepatitis-Associated Severe Aplastic Anemia: Looking for the Best Treatment. J Pediatr Gastroenterol Nutr. 2021 May 11.
PMID: 34016885
David C, Chaigne B, Hollande C, Terris B, Cohen P, Dunogue B, Terrier B, Sogni P, Goulvestre C, Mouthon L. Primary biliary cholangitis and systemic sclerosis (Reynolds syndrome): A case-control study. Autoimmun Rev. 2021 May 7;20(7):102842.
PMID: 33971338
Habes S, Gournay J, Milpied P, Conchon S, Renand A. [Peculiar profile of auto-reactive T lymphocytes in auto-immune hepatitis]. Med Sci (Paris). 2021 Apr;37(4):326-329.
PMID: 33908849
Tanaka A, Hirohara J, Nakano T, Matsumoto K, Chazouillères O, Takikawa H, Hansen BE, Carrat F, Corpechot C. Association of bezafibrate with transplant-free survival in patients with primary biliary cholangitis. J Hepatol. 2021 Apr 18:S0168-8278(21)00245-2.
PMID: 33882268
Soret PA, Lam L, Carrat F, Smets L, Berg T, Carbone M, Invernizzi P, Leroy V, Trivedi P, Cazzagon N, Weiler-Normann C, Alric L, Rosa-Hezode I, Heurgué A, Cervoni JP, Dumortier J, Potier P, Roux O, Silvain C, Bureau C, Anty R, Larrey D, Levy C, Pares A, Schramm C, Nevens F, Chazouillères O, Corpechot C. Combination of fibrates with obeticholic acid is able to normalise biochemical liver tests in patients with difficult-to-treat primary biliary cholangitis. Aliment Pharmacol Ther. 2021 Mar 25.
PMID: 33764590
Corpechot C. The revival of preemptive UDCA therapy in liver transplant recipients: Commentary to « UDCA decreases Incidence of Primary Biliary Cholangitis and Biliary Complications after Liver Transplant: A Meta-Analysis » by Pedersen et al., Liver Transplant, November 2020. Clin Res Hepatol Gastroenterol. 2021 Mar 13;45(3):101679.
PMID: 33727161
Khabou B, Hsairi M, Gargouri L, Miled N, Barbu V, Fakhfakh F. Characterization of a novel ABCC2 mutation in infantile Dubin Johnson syndrome. Clin Chim Acta. 2021 Mar 10;518:43-50.
PMID: 33713692
Gerussi A, Carbone M, Corpechot C, Schramm C, Asselta R, Invernizzi P. The genetic architecture of primary biliary cholangitis. Eur J Med Genet. 2021 Sep;64(9):104292. doi: 10.1016/j.ejmg.2021.104292. Epub 2021 Jul 23.
PMID: 34303876
Hirschfield GM, Chazouillères O, Cortez-Pinto H, Macedo G, de Lédinghen V, Adekunle F, Carbone M. A consensus integrated care pathway for patients with primary biliary cholangitis: a guideline-based approach to clinical care of patients. Expert Rev Gastroenterol Hepatol. 2021 Aug;15(8):929-939. doi: 10.1080/17474124.2021.1945919. Epub 2021 Jul 7.
PMID: 34233565
Maggiore G, Pietrobattista A, Liccardo D, Sciveres M, Nastasio S, Jacquemin E, Bernard O. Seronegative Autoimmune Hepatitis-associated Severe Aplastic Anemia: Looking for the Best Treatment. J Pediatr Gastroenterol Nutr. 2021 Aug 1;73(2):e48. doi: 10.1097/MPG.0000000000003165.
PMID: 34016885
Chazouillères O, Potier P, Bouzbib C, Hanslik B, Heurgue A, NGuyen-Khac E, Gournay J, Tanne F, Bureau C, Bourlière M, Ganne-Carrié N, de Lédinghen V. NON-INVASIVE DIAGNOSIS AND FOLLOW-UP OF PRIMARY SCLEROSING CHOLANGITIS. Clin Res Hepatol Gastroenterol. 2021 Jul 28:101775. doi: 10.1016/j.clinre.2021.101775. Online ahead of print.
PMID: 34332142
Corpechot C, Heurgue A, Decraecker M, Tanne F, Potier P, Hanslik B, de Lédinghen V, Ganne-Carrié N, Bureau C, Bourlière M. NON-INVASIVE DIAGNOSIS AND FOLLOW-UP OF PRIMARY BILIARY CHOLANGITIS. Clin Res Hepatol Gastroenterol. 2021 Jul 28:101770. doi: 10.1016/j.clinre.2021.101770. Online ahead of print.
PMID: 34332135
Lemoinne S, Heurgue A, Bouzbib C, Hanslik B, Gournay J, Nguyen-Khac E, Bureau C, de Lédinghen V, Ganne-Carrié N, Bourlière M. NON-INVASIVE DIAGNOSIS AND FOLLOW-UP OF AUTOIMMUNE HEPATITIS. Clin Res Hepatol Gastroenterol. 2021 Jul 28:101772. doi: 10.1016/j.clinre.2021.101772. Online ahead of print.
PMID: 34332126
Efe C, Lammert C, Taşçılar K, Dhanasekaran R, Ebik B, Higuera-de la Tijera F, Calışkan AR, Peralta M, Gerussi A, Massoumi H, Catana AM, Purnak T, Rigamonti C, Gomez Aldana AJ, Khakoo N, Nazal L, Frager S, Demir N, Irak K, Melekoğlu Ellik Z, Kacmaz H, Balaban Y, Atay K, Eren F, Alvares-da-Silva MR, Cristoferi L, Urzua Á, Eşkazan T, Magro B, Snijders R, Barutçu S, Lytvyak E, Miranda Zazueta G, Demirezer Bolat A, Aydın M, Heurgue-Berlot A, De Martin E, Ekin N, Yıldırım S, Yavuz A, Bıyık M, Castro Narro G, Kıyıcı M, Akyıldız M, Kahramanoğlu-Aksoy E, Vincent M, Carr RM, Günşar F, Cerda Reyes E, Harputoğlu M, Aloman C, Gatselis NK, Üstündağ Y, Brahm J, Chris Escajadillo Vargas N, Güzelbulut F, Ruiz Garcia S, Aguirre J, Anders M, Ratusnu N, Hatemi I, Mendizabal M, Floreani A, Fagiuoli S, Silva M, Idilman R, Satapathy SK, Silveira M, Drenth JPH, Dalekos GN, Assis DN, Björnsson E, Boyer JL, Yoshida EM, Invernizzi P, Levy C, Montano-Loza AJ, Schiano TD, Ridruejo E, Wahlin S. Effects of Immunosuppressive Drugs on COVID-19 severity in Patients with Autoimmune Hepatitis. Liver Int. 2021 Nov 30. doi: 10.1111/liv.15121. Online ahead of print.
PMID: 34846800
De Martin E, Duclos-Vallée JC. Reply to: « Validation of the SURFASA score to define steroid responsiveness in patients with acute autoimmune hepatitis ». J Hepatol. 2021 Nov 10:S0168-8278(21)02167-X. doi: 10.1016/j.jhep.2021.11.002. Online ahead of print.
PMID: 34774640
Bourdeleau P, Larrey E, Allaire M, Charlotte F, Vaillant JC, Lebray P. « De novo » Cholangiocarcinoma 20 years after liver transplantation for primary sclerosing cholangitis: Lifelong screening needed! Clin Res Hepatol Gastroenterol. 2021 Nov 2:101827. doi: 10.1016/j.clinre.2021.101827. Online ahead of print.
PMID: 34740844
Macek Jilkova Z, Hilleret MN, Gerster T, Sturm N, Mercey-Ressejac M, Zarski JP, Leroy V, Marche PN, Costentin C, Decaens T. Increased Intrahepatic Expression of Immune Checkpoint Molecules in Autoimmune Liver Disease. Cells. 2021 Oct 6;10(10):2671. doi: 10.3390/cells10102671.
PMID: 34685651
Murillo Perez CF, Harms MH, Lindor KD, van Buuren HR, Hirschfield GM, Corpechot C, van der Meer AJ, Feld JJ, Gulamhusein A, Lammers WJ, Ponsioen CY, Carbone M, Mason AL, Mayo MJ, Invernizzi P, Battezzati PM, Floreani A, Lleo A, Nevens F, Kowdley KV, Bruns T, Dalekos GN, Gatselis NK, Thorburn D, Trivedi PJ, Verhelst X, Parés A, Janssen HLA, Hansen BE; GLOBAL PBC Study Group. Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline Phosphatase. Am J Gastroenterol. 2020 Feb 20. doi: 10.14309
PMID: 32079858
Hedin CRH, Sado G, Ndegwa N, Lytvyak E, Mason A, Montano-Loza A, Gerussi A, Saffioti F, Thorburn D, Nilsson E, Larsson G, Moum BA, van Munster KN, Ponsioen CY, Levy C, Nogueira NF, Bowlus CL, Gotlieb N, Shibolet O, Lynch KD, Chapman RW, Rupp C, Vesterhus M, Jørgensen KK, Rorsman F, Schramm C, Sabino J, Vermeire S, Zago A, Cazzagon N, Marschal HU, Ytting H, Ben Belkacem K, Chazouilleres O, Almer S, Bergquist A; International PSC study group (IPSCSG). Effects of Tumor Necrosis Factor Antagonists in Patients With Primary Sclerosing Cholangitis. Clin Gastroenterol Hepatol. 2020 Feb 14. pii: S1542-3565(20)30182-8. doi: 10.1016
PMID: 32068151
Corpechot C, Barbu V, Chazouillères O, Broué P, Girard M, Roquelaure B, Chrétien Y, Dong C, Lascols O, Housset C, Jéru I. Genetic contribution of ABCC2 to Dubin-Johnson syndrome and inherited cholestatic disorders. Liver Int. 2020 Jan;40(1):163-174. doi: 10.1111/liv.14260. Epub 2019 Oct 13
PMID: 31544333
Corpechot C, Chazouillères O, Belnou P, Montano-Loza AJ, Mason A, Ebadi M, Eurich D, Chopra S, Jacob D, Schramm C, Sterneck M, Bruns T, Reuken P, Rauchfuss F, Roccarina D, Thorburn D, Gerussi A, Trivedi P, Hirschfield G, McDowell P, Nevens F, Boillot O, Bosch A, Giostra E, Conti F, Poupon R, Parés A, Reig A, Donato MF, Malinverno F, Floreani A, Russo FP, Cazzagon N, Verhelst X, Goet J, Harms M, van Buuren H, Hansen B, Carrat F, Dumortier J; Global PBC Study Group. Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis. J Hepatol. 2020 Apr 7:S0168-8278(20)30205-1. doi: 10.1016/j.jhep.2020.03.043. Online ahead of print.
PMID: 32275981
Housset C. Editorial: Cholangiocarcinoma – a rare and devastating, but no longer forsaken tumor.
Curr Opin Gastroenterol. 2020 Mar;36(2):55-56. doi: 10.1097/MOG.0000000000000604.
PMID: 31895233
Corpechot C, Rousseau A, Chazouillères O. Switching vs. add-on strategy in PBC treatment: Lessons from UDCA and bezafibrate experience. J Hepatol. 2020 Jun;72(6):1210-1211. doi: 10.1016/j.jhep.2019.12.027. Epub 2020 Mar 18.
PMID: 32199670
Hirschfield GM, Beuers U, Kupcinskas L, Ott P, Bergquist A, Färkkilä M, Manns MP, Parés A, Spengler U, Stiess M, Greinwald R, Pröls M, Wendum D, Drebber U, Poupon R. A placebo-controlled randomised trial of budesonide for primary biliary cholangitis following an insufficient response to UDCA. J Hepatol. 2020 Sep 17:S0168-8278(20)33623-0. doi: 10.1016/j.jhep.2020.09.011. Online ahead of print.
PMID: 32950590
Efe C, Torgutalp M, Henriksson I, Alalkim F, Lytvyak E, Trivedi H, Eren F, Fischer J, Chayanupatkul M, Coppo C, Purnak T, Muratori L, Werner M, Muratori P, Rorsman F, Onnerhag K, Nilsson E, Heurgué-Berlot A, Demir N, Semela D, Kıyıcı M, Schiano TD, Montano-Loza AJ, Berg T, Ozaslan E, Yoshida EM, Bonder A, Marschall HU, Beretta-Piccoli BT, Wahlin S. Extrahepatic autoimmune diseases in primary biliary cholangitis: Prevalence and significance for clinical presentation and disease outcome. J Gastroenterol Hepatol. 2020 Aug 13. doi: 10.1111/jgh.15214. Online ahead of print.
PMID: 32790935
Gerussi A, Bernasconi DP, O’Donnell SE, Lammers WJ, Buuren HV, Hirschfield G, Janssen H, Corpechot C, Reig A, Pares A, Battezzati PM, Zuin MG, Cazzagon N, Floreani A, Nevens F, Gatselis N, Dalekos G, Mayo MJ, Thorburn D, Bruns T, Mason AL, Verhelst X, Kowdley K, van der Meer A, Niro GA, Beretta-Piccoli BT, Marzioni M, Belli LS, Marra F, Valsecchi MG, Lindor KD, Invernizzi P, Hansen BE, Carbone M; Italian PBC Study Group and the GLOBAL PBC Study Group. Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary Cholangitis. Clin Gastroenterol Hepatol. 2020 Aug 7:S1542-3565(20)31083-1. doi: 10.1016/j.cgh.2020.08.006. Online ahead of print.
PMID: 32777554
Renand A, Cervera-Marzal I, Gil L, Dong C, Garcia A, Kervagoret E, Auble H, Habes S, Chevalier C, Vavasseur F, Clémenceau B, Cardon A, Judor JP, Mosnier JF, Tanné F, Laplaud DA, Brouard S, Gournay J, Milpied P, Conchon S. Integrative molecular profiling of autoreactive CD4 T cells in autoimmune hepatitis. J Hepatol. 2020 Jul 7:S0168-8278(20)30453-0. doi: 10.1016/j.jhep.2020.05.053. Online ahead of print.
PMID: 32649971
Montano-Loza AJ, Corpechot C. Definition and Management of Patients With Primary Biliary Cholangitis and an Incomplete Response to Therapy. Clin Gastroenterol Hepatol. 2020 Jul 3:S1542-3565(20)30926-5. doi: 10.1016/j.cgh.2020.06.062. Online ahead of print.
PMID: 32629125
Murillo Perez CF, Harms MH, Lindor KD, van Buuren HR, Hirschfield GM, Corpechot C, van der Meer AJ, Feld JJ, Gulamhusein A, Lammers WJ, Ponsioen CY, Carbone M, Mason AL, Mayo MJ, Invernizzi P, Battezzati PM, Floreani A, Lleo A, Nevens F, Kowdley KV, Bruns T, Dalekos GN, Gatselis NK, Thorburn D, Trivedi PJ, Verhelst X, Parés A, Janssen HLA, Hansen BE; GLOBAL PBC Study Group. Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline Phosphatase. Am J Gastroenterol. 2020 Jul;115(7):1066-1074. doi: 10.14309/ajg.0000000000000557.
PMID: 32618657
Renand A, Cervera-Marzal I, Gil L, Dong C, Garcia A, Kervagoret E, Auble H, Habes S, Chevalier C, Vavasseur F, Clémenceau B, Cardon A, Judor JP, Mosnier JF, Tanné F, Laplaud DA, Brouard S, Gournay J, Milpied P, Conchon S. Integrative molecular profiling of autoreactive CD4 T cells in autoimmune hepatitis. J Hepatol. 2020 Jul 7:S0168-8278(20)30453-0. doi: 10.1016/j.jhep.2020.05.053. Online ahead of print.
PMID: 32649971
Ben Merabet Y, Barbe C, Heurgue-Berlot A, Thévenot T, Minello A, Habersetzer F, Samuel D, Bernard-Chabert B, Weil-Verhoeven D, Renard P, Clot H, Di Martino V, Louvet H, Bresson-Hadni S, Thiéfin G. Sustained Remission After Treatment Withdrawal in Autoimmune Hepatitis: A Multicenter Retrospective Study. Dig Dis Sci. 2020 Jun 30. doi: 10.1007/s10620-020-06444-7. Online ahead of print.
PMID: 32607807
Irles-Depe M, Roullet S, Neau-Cransac M, Dumortier J, Dharancy S, Houssel-Debry P, Boillot O, Chiche L, Laurent C, Laharie D, De Lédinghen V. Impact of Pre-existing Inflammatory Bowel Disease on the Outcome of Liver Transplantation for Primary Sclerosing Cholangitis. Liver Transpl. 2020 Jun 30. doi: 10.1002/lt.25838. Online ahead of print.
PMID: 32603007
De Martin E, Rayar M, Golse N, Dupeux M, Gelli M, Gnemmi V, Allard MA, Cherqui D, Sa Cunha A, Adam R, Coilly A, Antonini TM, Guettier C, Samuel D, Boudjema K, Boleslawski E, Vibert E. Analysis of Liver Resection Versus Liver Transplantation on Outcome of Small Intrahepatic Cholangiocarcinoma and Combined Hepatocellular-Cholangiocarcinoma in the Setting of Cirrhosis. Liver Transpl. 2020 Jun;26(6):785-798. doi: 10.1002/lt.25737.
PMID: 32090444
Pariente A, Chazouilleres O, Causse X, Hanslik B, Arpurt JP, Henrion J, Rosa I, Renou C, Garioud A, Corpechot C; DESCRIPT; and DESCRIPT; Study Groups. Management of primary biliary cholangitis: results from a large real-life observational study in France and Belgium. Eur J Gastroenterol Hepatol. 2020 Nov 30. doi: 10.1097/MEG.0000000000002011. Online ahead of print.
PMID: 33252413
Irlès-Depé M, Roullet S, Neau-Cransac M, Dumortier J, Dharancy S, Houssel-Debry P, Boillot O, Chiche L, Laurent C, Laharie D, De Lédinghen V. Impact of Preexisting Inflammatory Bowel Disease on the Outcome of Liver Transplantation for Primary Sclerosing Cholangitis. Liver Transpl. 2020 Nov;26(11):1477-1491. doi: 10.1002/lt.25838. Epub 2020 Oct 22.
PMID: 32603007
Ackerman M, Esteve E, Potier P, Finon A. Two cases of yellow urticaria revealing acute lithiasic biliary disease. Australas J Dermatol. 2020 Nov 20. doi: 10.1111/ajd.13496. Online ahead of print.
PMID: 33216960
Couchonnal E, Jacquemin E, Lachaux A, Ackermann O, Gonzales E, Lacaille F, Debray D, Boillot O, Guillaud O, Wildhaber BE, Chouik Y, McLin V, Dumortier J. Long-term results of pediatric liver transplantation for autoimmune liver disease. Clin Res Hepatol Gastroenterol. 2020 Oct 16:S2210-7401(20)30275-8. doi: 10.1016/j.clinre.2020.08.013. Online ahead of print.
PMID: 33077391
Hirschfield GM, Beuers U, Kupcinskas L, Ott P, Bergquist A, Färkkilä M, Manns MP, Parés A, Spengler U, Stiess M, Greinwald R, Pröls M, Wendum D, Drebber U, Poupon R. A placebo-controlled randomised trial of budesonide for primary biliary cholangitis following an insufficient response to UDCA. J Hepatol. 2020 Sep 17:S0168-8278(20)33623-0. doi: 10.1016/j.jhep.2020.09.011. Online ahead of print.
PMID: 32950590
Lemoinne S, Kemgang A, Ben Belkacem K, Straube M, Jegou S, Corpechot C; Saint-Antoine IBD Network, Chazouillères O, Housset C, Sokol H. Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis. Gut. 2019 Apr 19. pii: gutjnl-2018-317791.
PMID: 31003979
Harms MH, van Buuren HR, Corpechot C, Thorburn D, Janssen HLA, Lindor KD, Hirschfield GM, Parés A, Floreani A, Mayo MJ, Invernizzi P, Battezzati PM, Nevens F, Ponsioen CY, Mason AL, Kowdley KV, Lammers WJ, Hansen BE, van der Meer AJ. Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis. J Hepatol. 2019 Apr 11.
PMID: 30980847
Ciocan D, Voican CS, Barbu V, Corpechot C, Rainteau D, Prevot S, Lebrun A, Perlemuter G. Intrahepatic Cholestasis Owing to a Novel Heterozygous ABCG8 Mutation and SLC4A2 Polymorphism With Favorable Outcome Under Ursodeoxycholic Acid. Am J Gastroenterol. 2019 Jul 22. doi: 10.14309/ajg.
PMID: 31335361
Gatselis NK, Goet JC, Zachou K, Lammers WJ, Janssen HLA, Hirschfield G, Corpechot C, Lindor KD, Invernizzi P, Mayo MJ, Battezzati PM, Floreani A, Pares A, Lygoura V, Nevens F, Mason AL, Kowdley KV, Ponsioen CY, Bruns T, Thorburn D, Verhelst X, Harms MH, van Buuren HR, Hansen BE, Dalekos GN; Global PBC Study Group. Factors Associated With Progression and Outcomes of Early-stage Primary Biliary Cholangitis. Clin Gastroenterol Hepatol. 2019 Aug 13.
PMID: 31419573
Corpechot C, Chazouillères O. A Brief Reflection on Continuous vs Binary Risk Indicators in Primary Biliary Cholangitis. Am J Gastroenterol. 2019 Aug 14. doi: 10.14309/ajg.
PMID: 31425151
Khabou B, Trigui A, Boudawara TS, Keskes L, Kamoun H, Barbu V, Fakhfakh F. A homozygous ABCB4 mutation causing an LPAC syndrome evolves into cholangiocarcinoma. Clin Chim Acta. 2019 Aug;495:598-605. doi: 10.1016/j.cca.2019.06.007.
PMID: 31181191w
Harms MH, de Veer RC, Lammers WJ, Corpechot C, Thorburn D, Janssen HLA, Lindor KD, Trivedi PJ, Hirschfield GM, Pares A, Floreani A, Mayo MJ, Invernizzi P, Battezzati PM, Nevens F, Ponsioen CY, Mason AL, Kowdley KV, Hansen BE, Buuren HRV, van der Meer AJ. Number needed to treat with ursodeoxycholic acid therapy to prevent liver transplantation or death in primary biliary cholangitis. Gut. 2019 Dec 16. pii: gutjnl-2019-319057. doi: 10.1136
PMID: 31843787
Cazzagon N, Lemoinne S, El Mouhadi S, Trivedi PJ, Gaouar F, Kemgang A, Ben Belkacem K, Floreani A, Hirschfield G, Chretien Y, Housset C, Motta R, Russo FP, Chazouillères O, Arrivé L, Corpechot C. The Complementary Value of Magnetic Resonance Imaging and Vibration-Controlled Transient Elastography for Risk Stratification in Primary Sclerosing Cholangitis. Am J Gastroenterol. 2019 Dec;114(12):1878-1885.
PMID: 31738286
Murillo Perez CF, Hirschfield GM, Corpechot C, Floreani A, Mayo MJ, van der Meer A, Ponsioen CY, Lammers WJ, Parés A, Invernizzi P, Carbone M, Maria Battezzati P, Nevens F, Kowdley KV, Thorburn D, Mason AL, Trivedi PJ, Lindor KD, Bruns T, Dalekos GN, Gatselis NK, Verhelst X, Janssen HLA, Hansen BE, Gulamhusein A; GLOBAL PBC Study Group. Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment response. Aliment Pharmacol Ther. 2019 Nov;50(10):1127-1136.
PMID: 31621931
Lemoinne S, Cazzagon N, El Mouhadi S, Trivedi PJ, Dohan A, Kemgang A, Ben Belkacem K, Housset C, Chretien Y, Corpechot C, Hirschfield G, Floreani A, Motta R, Gallix B, Barkun A, Barkun J, Chazouillères O, Arrivé L. Simple Magnetic Resonance Scores Associate With Outcomes of Patients With Primary Sclerosing Cholangitis. Clin Gastroenterol Hepatol. 2019 Dec;17(13):2785-2792.e3
PMID: 30880273
Maladies Vasculaires du Foie
Kiladjian JJ, Cassinat B. MYELOPROLIFERATIVE NEOPLASMS AND SPLANCHNIC VEIN THROMBOSIS: CONTEMPORARY DIAGNOSTIC AND THERAPEUTIC STRATEGIES. Am J Hematol. 2023 Mar 4. doi: 10.1002/ajh.26896. Online ahead of print.
PMID: 36869873
Artru F, Rautou PE, Denys A. Letter to the editor: discussing the place of TIPS in noncirrhotic patients with chronic extrahepatic portal vein occlusion (EHPVO). Hepatology. 2023 Jan 3. doi: 10.1097/HEP.0000000000000038. Online ahead of print.
PMID: 36647595
Plessier A, Goria O, Cervoni JP, Ollivier I, Bureau C, Poujol-Robert A, Minello A, Houssel-Debry P, Rautou PE, Payancé A, Scoazec G, Bruno O, Corbic M, Durand F, Vilgrain V, Paradis V, Boudaoud L, de Raucourt E, Roy C, Gault N, Valla D. Rivaroxaban Prophylaxis in Noncirrhotic Portal Vein Thrombosis. NEJM Evidence. 2022 Nov 22. doi: 10.1056/EVIDoa2200104.
https://doi.org/10.1056/EVIDoa2200104
Magaz M, Giudicelli-Lett H, Rautou PE, Durand F, García-Pagán JC. Reply to « Liver Transplantation for Porto-sinusoidal Vascular Liver Disorder: Long-term Outcome ».
Transplantation. 2023 Jun 1;107(6):e187. doi: 10.1097/TP.0000000000004611. Epub 2023 May 23.
PMID: 37088905
Magaz M, Giudicelli-Lett H, Nicoară-Farcău O, Rajoriya N, Goel A, Raymenants K, Hillaire S, Crespo G, Téllez L, Elkrief L, Fondevila C, Orts L, Nery F, Shukla A, Larrue H, Fundora Y, Degroote H, Aguilera V, LLop E, Turco L, Indulti F, Gioia S, Tosetti G, Bitto N, Becchetti C, Alvarado E, Roig C, Diaz R, Praktiknjo M, Konicek AL, Soy G, Olivas P, Fortea JI, Masnou H, Puente Á, Ardèvol A, Álvarez-Navascués C, Romero M, Scheiner B, Semmler G, Mandorfer M, Damião F, Baiges A, Turon F, Simón-Talero M, González-Alayón C, Díaz A, García-Criado Á, de Gottardi A, Reverter E, Blasi A, Genescà J, Roux O, Francoz C, Noronha Ferreira C, Reiberger T, Rodríguez M, Morillas RM, Crespo J, Trebicka J, Bañares R, Villanueva C, Berzigotti A, Primignani M, La Mura V, Riggio O, Schepis F, Procopet B, Verhelst X, Calleja JL, Bureau C, Albillos A, Nevens F, Hernández-Gea V, Tripathi D, Rautou PE, Durand F, García-Pagán JC.
Transplantation. 2023 Jun 1;107(6):1330-1340. doi: 10.1097/TP.0000000000004444. Epub 2023 May 23. Liver Transplantation for Porto-sinusoidal Vascular Liver Disorder: Long-term Outcome.
PMID: 36479977
Garcia-Pagán JC, Valla DC. Primary Budd-Chiari Syndrome.
N Engl J Med. 2023 Apr 6;388(14):1307-1316. doi: 10.1056/NEJMra2207738.
PMID: 37018494
Dumortier J, Rebaudet H, Champagnac J, Valette PJ. Portal-hepatic venous shunt in a patient with trisomy 21.
Clin Res Hepatol Gastroenterol. 2023 May;47(5):102122. doi: 10.1016/j.clinre.2023.102122. Epub 2023 Apr 5.
PMID: 37028487
Elkrief L, Payancé A, Plessier A, d’Alteroche L, Ronot M, Paradis V, Valla D, Rautou PE. Management of splanchnic vein thrombosis.
JHEP Rep. 2023 Jan 3;5(4):100667. doi: 10.1016/j.jhepr.2022.100667. eCollection 2023 Apr.
PMID: 36941824
Girard C, Laborde N, Marbach C, Mas E, Bureau C, Broué P. Porto-Sinusoidal Vascular Disease: A Pediatric Study Of 30 Patients. J Pediatr Gastroenterol Nutr. 2022 Mar 8. doi: 10.1097/MPG.0000000000003445. Online ahead of print.
PMID: 35258501
Ollivier-Hourmand I, Allaire M, Cervoni JP; Club Francophone pour l’Etude de l’Hypertension Portale.
Management of portal hypertension in patients treated with Atezolizumab and Bevacizumab for hepatocellular carcinoma. J Hepatol. 2022 Feb 16:S0168-8278(22)00079-4. doi: 10.1016/j.jhep.2022.02.004. Online ahead of print.
PMID: 35182660
Plessier A, Esposito-Farèse M, Baiges A, Shukla A, Pagan JCG, De Raucourt E, Ollivier-Hourmand I, Cervoni JP, De Ledinghen V, Tazi Z, Nousbaum JB, Bun R, Bureau C, Silvain C, Tournilhac O, Gerfaud-Valentin M, Durand F, Goria O, Tellez L, Albillos A, Gioia S, Riggio O, De Gottardi A, Payance A, Rautou PE, Terriou L, Charbonnier A, Elkrief L, de la Tour RP, Valla DC, Gault N, de Fontbrune FS. Paroxysmal nocturnal hemoglobinuria and vascular liver disease: Eculizumab therapy decreases mortality and thrombotic complications. Am J Hematol. 2022 Apr;97(4):431-439. doi: 10.1002/ajh.26474. Epub 2022 Jan 31.
PMID: 35049058
Valainathan SR, Sartoris R, Elkrief L, Magaz M, Betancourt F, Pellegrino S, Nivolli A, Dioguardi Burgio M, Flattet Y, Terraz S, Drilhon N, Lazareth M, Herrou J, Bruno O, Payance A, Plessier A, Durand F, Ronot M, Valla DC, Paradis V, Garcia-Pagan JC, Vilgrain V, Rautou PE. Contrast-enhanced CT and liver surface nodularity for the diagnosis of porto-sinusoidal vascular disorder: A case-control study. Hepatology. 2022 Jan 29. doi: 10.1002/hep.32367. Online ahead of print.
PMID: 35092315
de Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C; Baveno VII Faculty. Baveno VII – Renewing consensus in portal hypertension. J Hepatol. 2021 Dec 30:S0168-8278(21)02299-6. doi: 10.1016/j.jhep.2021.12.022. Online ahead of print.
PMID: 35120736
Ackermann O, Darmellah-Remil A, Bernard O, Boytchev I, Staiti G, Gonzalès E, Jacquemin E, Duché M. Efficacy and safety of endoscopic primary prophylaxis of bleeding in children with high-risk gastroesophageal varices. J Pediatr Gastroenterol Nutr. 2022 Jun 16. doi: 10.1097/MPG.0000000000003529. Online ahead of print.
PMID: 35706101
Boillot O, Chopinet S, Gregoire E, Milot L, Petit P, Rohmer B, Roquelaure B, Dariel A, Panait N, Hardwigsen J, Dumortier J. Partial splenectomy in children undergoing liver transplantation or venous shunt for severe hypersplenism: a case control comparative study. Clin Res Hepatol Gastroenterol. 2022 Apr 21:101929. doi: 10.1016/j.clinre.2022.101929. Online ahead of print.
PMID: 35462062
Tripathi D, Bureau C. Prophylactic embolization of large spontaneous portosystemic shunts with transjugular intrahepatic portosystemic shunt (TIPS): A panacea for post-TIPS hepatic encephalopathy? Hepatology. 2022 Apr 16. doi: 10.1002/hep.32525. Online ahead of print.
PMID: 35429167
De Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C; Baveno VII Faculty. Corrigendum to ‘Baveno VII – Renewing consensus in portal hypertension’ [J Hepatol (2022) 959-974]. J Hepatol. 2022 Jul;77(1):271. doi: 10.1016/j.jhep.2022.03.024. Epub 2022 Apr 14.
PMID: 35431106
Cannella R, Tselikas L, Douane F, Cauchy F, Rautou PE, Duran R, Ronot M. Imaging-guided interventions modulating portal venous flow: Evidence and controversies. JHEP Rep. 2022 Apr 4;4(7):100484. doi: 10.1016/j.jhepr.2022.100484. eCollection 2022 Jul.
PMID: 35677591
Girard C, Laborde N, Marbach C, Mas E, Bureau C, Broué P. Porto-Sinusoidal Vascular Disease: A Pediatric Study Of 30 Patients. J Pediatr Gastroenterol Nutr. 2022 Mar 8. doi: 10.1097/MPG.0000000000003445. Online ahead of print.
PMID: 35258501
Magaz M, Giudicelli-Lett H, Nicoară-Farcău O, Rajoriya N, Goel A, Raymenants K, Hillaire S, Crespo G, Téllez L, Elkrief L, Fondevila C, Orts L, Nery F, Shukla A, Larrue H, Fundora Y, Degroote H, Aguilera V, LLop E, Turco L, Indulti F, Gioia S, Tosetti G, Bitto N, Becchetti C, Alvarado E, Roig C, Diaz R, Praktiknjo M, Konicek AL, Soy G, Olivas P, Fortea JI, Masnou H, Puente Á, Ardèvol A, Álvarez-Navascués C, Romero M, Scheiner B, Semmler G, Mandorfer M, Damião F, Baiges A, Turon F, Simón-Talero M, González-Alayón C, Díaz A, García-Criado Á, de Gottardi A, Reverter E, Blasi A, Genescà J, Roux O, Francoz C, Noronha Ferreira C, Reiberger T, Rodríguez M, Morillas RM, Crespo J, Trebicka J, Bañares R, Villanueva C, Berzigotti A, Primignani M, La Mura V, Riggio O, Schepis F, Procopet B, Verhelst X, Calleja JL, Bureau C, Albillos A, Nevens F, Hernández-Gea V, Tripathi D, Rautou PE, Durand F, García-Pagán JC. Liver Transplantation for Porto-Sinusoidal Vascular Liver Disorder: Long-term Outcome. Transplantation. 2022 Dec 9. doi: 10.1097/TP.0000000000004444. Online ahead of print.
PMID: 36479977
Ackermann O, Darmellah-Remil A, Bernard O, Boytchev I, Staiti G, Gonzalès E, Jacquemin E, Duché M. Efficacy and Safety of Endoscopic Primary Prophylaxis of Bleeding in Children With High-Risk Gastroesophageal Varices. J Pediatr Gastroenterol Nutr. 2022 Oct 1;75(4):491-496. doi: 10.1097/MPG.0000000000003529. Epub 2022 Jun 16.
PMID: 35706101
Larrue H, Bureau C. Transjugular intrahepatic portosystemic shunt in portal hypertension: How to go further while staying on track? Hepatology. 2022 Sep 15. doi: 10.1002/hep.32789. Online ahead of print.
PMID: 36106380
Baiges A, Procopet B, Silva-Junior G, Llop E, Tellez L, Darnell A, Garcia-Criado Á, Turon F, Nicoara-Farcau O, González-Alayón C, Larrue H, Magaz M, Olivas P, Perez-Campuzano V, Calleja JL, Albillos A, Reverter JC, Bureau C, Bosch J, Hernández-Gea V, Garcia-Pagán JC; REHEVASC; VALDIG; an EASL consortium. Incidence and factors predictive of recurrent thrombosis in people with non-cirrhotic portal vein thrombosis. J Hepatol. 2022 Sep 2:S0168-8278(22)03054-9. doi: 10.1016/j.jhep.2022.08.023. Online ahead of print.
PMID: 36058365
Gressens SB, Cazals-Hatem D, Lloyd V, Plessier A, Payancé A, Lebrec D, Durand F, Socie G, Valla D, Paradis V, Michonneau D, Rautou PE. Hepatic venous pressure gradient in sinusoidal obstruction syndrome: diagnostic value and link with histological lesions. JHEP Rep. 2022 Aug 17;4(11):100558. doi: 10.1016/j.jhepr.2022.100558. eCollection 2022 Nov.
PMID: 36160755
Korff S, Mostaguir K, Beghetti M, D’Antiga L, Debray D, Franchi-Abella S, Gonzales E, Guerin F, Hachulla AL, Lambert V, Makrythanasis P, Roduit N, Savale L, Senat MV, Spaltenstein J, van Steenbeek F, Wildhaber BE, Zwahlen M, McLin VA. International registry of congenital porto-systemic shunts: a multi-centre, retrospective and prospective registry of neonates, children and adults with congenital porto-systemic shunts. Orphanet J Rare Dis. 2022 Jul 19;17(1):284. doi: 10.1186/s13023-022-02412-8.
PMID: 35854389
Artru F, Vietti-Violi N, Sempoux C, Vieira Barbosa J, Becce F, Sah N, Marot A, Deltenre P, Moschouri E, Fraga M, Hocquelet A, Duran R, Moradpour D, Rautou PE, Denys A. Portal vein recanalisation alone to treat severe portal hypertension in non-cirrhotic patients with chronic extrahepatic portal vein obstruction. JHEP Rep. 2022 May 25;4(8):100511. doi: 10.1016/j.jhepr.2022.100511. eCollection 2022 Aug.
PMID: 35801087
Bureau C, Thabut D, Jezequel C, Archambeaud I, D’Alteroche L, Dharancy S, Borentain P, Oberti F, Plessier A, De Ledinghen V, Ganne-Carrié N, Carbonell N, Rousseau V, Sommet A, Péron JM, Vinel JP. The Use of Rifaximin in the Prevention of Overt Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt: A Randomized Controlled Trial. Ann Intern Med. 2021 Feb 2. doi: 10.7326/M20-0202. Online ahead of print.
PMID: 33524293
Trebicka J, Gu W, de Ledinghen V, Aubé C, Krag A, Praktiknjo M, Castera L, Dumortier J, Bauer DJM, Friedrich-Rust M, Pol S, Grgurevic I, Zheng R, Francque S, Gottfriedovà H, Mustapic S, Sporea I, Berzigotti A, Uschner FE, Simbrunner B, Ronot M, Cassinotto C, Kjaergaard M, Andrade F, Schulz M, Semmler G, Drinkovic IT, Chang J, Brol MJ, Rautou PE, Vanwolleghem T, Strassburg CP, Boursier J, Ferstl PG, Rasmussen DN, Reiberger T, Vilgrain V, Guibal A, Guillaud O, Zeuzem S, Vassord C, Lu X, Vonghia L, Senkerikova R, Popescu A, Margini C, Wang W, Thiele M, Jansen C. Two-dimensional shear wave elastography predicts survival in advanced chronic liver disease. Gut. 2021 Jan 21:gutjnl-2020-323419. doi: 10.1136/gutjnl-2020-323419. Online ahead of print.
PMID: 33479052
Elkrief L, Lazareth M, Chevret S, Paradis V, Magaz M, Blaise L, Rubbia-Brandt L, Moga L, Durand F, Payancé A, Plessier A, Chaffaut C, Valla D, Malphettes M, Diaz A, Nault JC, Nahon P, Audureau E, Ratziu V, Castera L, Garcia Pagan JC, Ganne-Carrie N, Rautou PE; ANRS CO12 CirVir group. Liver stiffness by transient elastography to detect porto-sinusoidal vascular liver disease with portal hypertension. Hepatology. 2020 Dec 21. doi: 10.1002/hep.31688. Online ahead of print.
PMID: 33345307
Hillmen P, Szer J, Weitz I, Röth A, Höchsmann B, Panse J, Usuki K, Griffin M, Kiladjian JJ, de Castro C, Nishimori H, Tan L, Hamdani M, Deschatelets P, Francois C, Grossi F, Ajayi T, Risitano A, de la Tour RP. Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria. N Engl J Med. 2021 Mar 18;384(11):1028-1037.
PMID: 33730455
Réau V, Vallée A, Terrier B, Plessier A, Abisror N, Ackermann F, Benainous R, Bohelay G, Chabi-Charvillat ML, Cornec D, Desbois AC, Faguer S, Freymond N, Gaillet A, Hamidou M, Killian M, Le Jeune S, Marchetti A, Meyer G, Osorio-Perez F, Panel K, Rautou PE, Rohmer J, Simon N, Tcherakian C, Vasse M, Zuelgaray E, Lefevre G, Kahn JE, Groh M. Venous thrombosis and predictors of relapse in eosinophil-related diseases. Sci Rep. 2021 Mar 18;11(1):6388.
PMID: 33737704
Debureaux PE, Bourrier P, Rautou PE, Zagdanski AM, De Boutiny M, Pagliuca S, Sutra Del Galy A, Robin M, Peffault de Latour R, Plessier A, Sicre de Fontbrune F, Xhaard A, de Lima Prata PH, Valla D, Socié G, Michonneau D. Elastography improves accuracy of early hepato-biliary complications diagnosis after allogeneic stem cell transplantation. Haematologica. 2021 Sep 1;106(9):2374-2383. doi: 10.3324/haematol.2019.245407.
PMID: 32732366
Campion B, Larrey E, Wagner M, Rudler M, Thabut D, Allaire M. Portal hypertension, advanced hepatocellular carcinoma and therapy by atezolizumab-bevacizumab: a « menage à trois » ! Clin Res Hepatol Gastroenterol. 2021 Aug 9:101785. doi: 10.1016/j.clinre.2021.101785. Online ahead of print.
PMID: 34384926
Allaire M, Garcia-Pagán JC, Walter A, Bureau C, Thabut D. Salvage TIPS in cirrhotic patients with variceal bleeding: MELD, lactates and « à la carte » decision. Hepatology. 2021 Aug 5. doi: 10.1002/hep.32091. Online ahead of print.
PMID: 34351661
Rautou PE, Elkrief L, Decraecker M, Ollivier-Hourmand I, Plessier A, Ronot M, Vilgrain V, Bourlière M, Ganne-Carrié N, de Lédinghen V, Bureau C. NON-INVASIVE DIAGNOSIS AND FOLLOW-UP OF VASCULAR LIVER DISEASES. Clin Res Hepatol Gastroenterol. 2021 Jul 28:101764. doi: 10.1016/j.clinre.2021.101764. Online ahead of print.
PMID: 34332130
Thabut D, Weil D, Bouzbib C, Rudler M, Cassinotto C, Castéra L, Serste T, Oberti F, Ganne-Carrié N, de Lédinghen V, Bourlière M, Bureau C. NON-INVASIVE DIAGNOSIS AND FOLLOW-UP OF PORTAL HYPERTENSION. Clin Res Hepatol Gastroenterol. 2021 Jul 28:101767. doi: 10.1016/j.clinre.2021.101767. Online ahead of print.
PMID: 34332128
Stempak-Droissart T, Rousset-Jablonski C, Spritzer PM, Lalhou N, Larger E, Pichard C, Plessier A, Gompel A. Impact of vascular liver disease on the menstrual cycle and metabolic status in premenopausal women. Clin Res Hepatol Gastroenterol. 2021 Jul 21:101756. doi: 10.1016/j.clinre.2021.101756. Online ahead of print.
PMID: 34303004
Allaire M, Rudler M, Thabut D. Portal hypertension and hepatocellular carcinoma: Des liaisons dangereuses…. Liver Int. 2021 Aug;41(8):1734-1743. doi: 10.1111/liv.14977. Epub 2021 Jun 28.
PMID: 34051060
Elkrief L, Lazareth M, Chevret S, Paradis V, Magaz M, Blaise L, Rubbia-Brandt L, Moga L, Durand F, Payancé A, Plessier A, Chaffaut C, Valla D, Malphettes M, Diaz A, Nault JC, Nahon P, Audureau E, Ratziu V, Castera L, Garcia Pagan JC, Ganne-Carrie N, Rautou PE; ANRS CO12 CirVir Group. Liver Stiffness by Transient Elastography to Detect Porto-Sinusoidal Vascular Liver Disease With Portal Hypertension. Hepatology. 2021 Jul;74(1):364-378. doi: 10.1002/hep.31688. Epub 2021 Jun 11.
PMID: 33345307
Panvini N, Dioguardi Burgio M, Sartoris R, Maino C, Van Wettere M, Plessier A, Payence A, Rautou PE, Ladouceur M, Vilgrain V, Ronot M. MR imaging features and long-term evolution of benign focal liver lesions in Budd-Chiari syndrome and Fontan-associated liver disease. Diagn Interv Imaging. 2021 Oct 12:S2211-5684(21)00198-4. doi: 10.1016/j.diii.2021.09.001. Online ahead of print.
PMID: 34654671
De Broucker C, Plessier A, Ollivier-Hourmand I, Dharancy S, Bureau C, Cervoni JP, Sogni P, Goria O, Corcos O, Sartoris R, Ronot M, Vilgrain V, de Raucourt E, Zekrini K, Davy H, Durand F, Payancé A, Fidouh-Houhou N, Yazdanpanah Y, Valla D, Rautou PE. Multicenter study on recent portal venous system thrombosis associated with cytomegalovirus disease. J Hepatol. 2021 Sep 23:S0168-8278(21)02041-9. doi: 10.1016/j.jhep.2021.09.011. Online ahead of print.
PMID: 34563580
Allaire M, Garcia-Pagán JC, Walter A, Bureau C, Thabut D. Letter to the Editor: Salvage TIPS in Patients With Cirrhosis With Variceal Bleeding: MELD, Lactates, and « à la Carte » Decision. Hepatology. 2021 Dec;74(6):3558-3559. doi: 10.1002/hep.32091. Epub 2021 Sep 16.
PMID: 34351661
Valla DC. Recent developments in the field of vascular liver diseases. Liver Int. 2020 Feb;40 Suppl 1:142-148. doi: 10.1111
PMID: 32077611
Xu X, Xu S, Primignani M, De Stefano V, He Y, Yi F, Guo X, Valla D, Qi X. Nonselective β-Blockers May Progress the Thrombosis of Portal Venous System in Cirrhotic Patients: A Retrospective Observational Study. Adv Ther. 2020 Feb 19. doi: 10.1007
PMID: 32076942
Desbois AC, Plessier A. Why and when to diagnose Behcet’s disease in patients with Budd Chiari Syndrome? Clin Res Hepatol Gastroenterol. 2020 Jan 6. pii: S2210-7401(19)30264-5. doi: 10.1016
PMID: 31917175
David A, Metairie S, Perret C, Schnee M, Archambeaud I, Frampas E, Douane F. Minilaparotomy-assisted transmesenteric approach for portal vein recanalization and transjugular intrahepatic portosystemic shunt in a non-cirrhotic patient with portal cavernoma. Diagn Interv Imaging. 2019 Dec 31. pii: S2211-5684(19)30276-1. doi: 10.1016
PMID: 31899148
Goria O, Archambeaud I, Lemaitre C, Dutheil D, Plessier A, Rautou PE, Hernandez-Gea V, Valla D. Ischemic cholangiopathy: An update. Clin Res Hepatol Gastroenterol. 2020 May 24:S2210-7401(20)30093-0. doi: 10.1016/j.clinre.2020.03.018. Online ahead of print.
PMID: 32461060
Heurgué A, Habes D, Brugel M, Franchi-Abella S, Condat B, Valla D, Hillaire S, Debray D, Hernandez-Gea V, Dutheil D, Plessier A, Bureau C, Payancé A. Recent (non-cirrhotic) extrahepatic portal vein obstruction. Clin Res Hepatol Gastroenterol. 2020 May 21:S2210-7401(20)30074-7. doi: 10.1016/j.clinre.2020.03.003. Online ahead of print.
PMID: 32448586
Larrey D, Meunier L, Valla D, Hillaire S, Hernandez-Gea V, Dutheil D, Plessier A, Bureau C. Drug induced liver injury and vascular liver disease. Clin Res Hepatol Gastroenterol. 2020 May 1:S2210-7401(20)30095-4. doi: 10.1016/j.clinre.2020.03.020. Online ahead of print.
PMID: 32371005
Poisson J, Tanguy M, Davy H, Camara F, El Mdawar MB, Kheloufi M, Dagher T, Devue C, Lasselin J, Plessier A, Merchant S, Blanc-Brude O, Souyri M, Mougenot N, Dingli F, Loew D, Hatem SN, James C, Villeval JL, Boulanger CM, Rautou PE. Erythrocyte-derived microvesicles induce arterial spasms in JAK2V617F myeloproliferative neoplasm. J Clin Invest. 2020 May 1;130(5):2630-2643. doi: 10.1172/JCI124566.
PMID: 32045382
Plessier A, Bureau C. « Vascular liver diseases: Position paper(s) from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and the European Reference Network on Hepatological Diseases (ERN RARE-LIVER) ». Clin Res Hepatol Gastroenterol. 2020 Apr 29:S2210-7401(20)30080-2. doi: 10.1016/j.clinre.2020.03.009. Online ahead of print.
PMID: 32360056
Plessier A, Gasperment M, Debray D, Le Beux E, Brault C, Ollivier-Hourmand I, Dutheil D, Leclercq A, Devictor J, Hernández-Gea V, Pierre Emmanuel R, Goria O. Social and medical support initiatives in vascular liver diseases in France, from child to adult. Clin Res Hepatol Gastroenterol. 2020 Apr 27:S2210-7401(20)30073-5. doi: 10.1016/j.clinre.2020.03.002. Online ahead of print.
PMID: 32354585
Giudicelli H, Rautou PE, Paradis V, Bedossa P, Goria O, Lambert V, Hernandez-Gea V, Dutheil D, Plessier A, Bureau C, Valla D. Porto-sinusoidal vascular disease. Vascular liver diseases: Position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver. Clin Res Hepatol Gastroenterol. 2020 Apr 22:S2210-7401(20)30076-0. doi: 10.1016/j.clinre.2020.03.005. Online ahead of print.
PMID: 32335045
Abergel A, Gasperment M, Nery FG, Buchard B, Lebreton A, Hordonneau C, Duron C, Valla D, Sophie H, Ledain-Rautou E, Hernandez-Gea V, Dutheil D, Plessier A, Bureau C, Francoz C. Extrahepatic portal vein obstruction (EHPVO) in cirrhosis. Clin Res Hepatol Gastroenterol. 2020 Apr 17:S2210-7401(20)30089-9. doi: 10.1016/j.clinre.2020.03.014. Online ahead of print.
PMID: 32312599
Guérin F, Franchi Abella S, McLin V, Ackermann O, Girard M, Cervoni JP, Savale L, Hernandez-Gea V, Valla D, Hillaire S, Dutheil D, Bureau C, Gonzales E, Plessier A. Congenital portosystemic shunts: Vascular liver diseases: Position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver. Clin Res Hepatol Gastroenterol. 2020 Apr 9:S2210-7401(20)30075-9. doi: 10.1016/j.clinre.2020.03.004. Online ahead of print.
PMID: 32279979
Ollivier-Hourmand I, Nguyen N, De Gottardi A, Valla D, Hillaire S, Dutheil D, Bureau C, Hernandez-Gea V, De Raucourt E, Plessier A. Management of anticoagulation in adult patients with chronic parenchymal or vascular liver disease: Vascular liver diseases: Position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver. Clin Res Hepatol Gastroenterol. 2020 Apr 8:S2210-7401(20)30077-2. doi: 10.1016/j.clinre.2020.03.006. Online ahead of print.
PMID: 32278777
Payancé A, Ceccaldi PF, De Raucourt E, Valla D, Hillaire S, Dutheil D, Hernandez-Gea V, Bureau C, Plessier A. Pregnancy and vascular liver diseases: Vascular liver diseases: position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver. Clin Res Hepatol Gastroenterol. 2020 Apr 8:S2210-7401(20)30078-4. doi: 10.1016/j.clinre.2020.03.007. Online ahead of print.
PMID: 32278776
Silvain C, Thévenot T, Colle I, Vilgrain V, Dupuis-Girod S, Buscarini E, Valla D, Hillaire S, Dutheil D, Sitbon O, Bureau C, Plessier A. Hereditary hemorrhagic telangiectasia and liver involvement: Vascular liver diseases: position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver. Clin Res Hepatol Gastroenterol. 2020 Apr 7:S2210-7401(20)30079-6. doi: 10.1016/j.clinre.2020.03.008. Online ahead of print.
PMID: 32276767
de Lédinghen V, Villate A, Robin M, Decraecker M, Valla D, Hillaire S, Hernandez-Gea V, Dutheil D, Bureau C, Plessier A. Sinusoidal obstruction syndrome. Clin Res Hepatol Gastroenterol. 2020 Apr 3:S2210-7401(20)30094-2. doi: 10.1016/j.clinre.2020.03.019. Online ahead of print.
PMID: 32253162
Coilly A, Potier P, Broué P, Kounis I, Valla D, Hillaire S, Lambert V, Dutheil D, Hernández-Gea V, Plessier A, Vilgrain V, Bureau C. Budd-Chiari syndrome. Clin Res Hepatol Gastroenterol. 2020 Apr 2:S2210-7401(20)30090-5. doi: 10.1016/j.clinre.2020.03.015. Online ahead of print.
PMID: 32249150
Van Wettere M, Paulatto L, Raynaud L, Bruno O, Payancé A, Plessier A, Rautou PE, Paradis V, Cazals-Hatem D, Valla D, Vilgrain V, Ronot M. Hepatobiliary MR contrast agents are useful to diagnose hepatocellular carcinoma in patients with Budd-Chiari syndrome. JHEP Rep. 2020 Mar 9;2(3):100097. doi: 10.1016/j.jhepr.2020.100097. eCollection 2020 Jun.
PMID: 32435753
Elkrief L, Houssel-Debry P, Ackermann O, Franchi-Abella S, Branchereau S, Valla D, Hillaire S, Dutheil D, Plessier A, Hernandez-Gea V, Bureau C. Portal cavernoma or chronic non cirrhotic extrahepatic portal vein obstruction. Clin Res Hepatol Gastroenterol. 2020 Sep;44(4):491-496. doi: 10.1016/j.clinre.2020.03.016. Epub 2020 Aug 17.
PMID: 32819872
Debureaux PE, Cassinat B, Soret-Dulphy J, Mora B, Verger E, Maslah N, Plessier A, Rautou PE, Ollivier-Hourman I, De Ledinghen V, Goria O, Bureau C, Siracusa C, Valla D, Giraudier S, Passamonti F, Kiladjian JJ. Molecular profiling and risk classification of patients with myeloproliferative neoplasms and splanchnic vein thromboses. Blood Adv. 2020 Aug 11;4(15):3708-3715. doi: 10.1182/bloodadvances.2020002414.
PMID: 32777065
Souhami A, Sartoris R, Rautou PE, Cauchy F, Bouattour M, Durand F, Gianelli V, Gigante E, Castera L, Valla D, Soubrane O, Vilgrain V, Ronot M. Similar performance of liver stiffness measurement and liver surface nodularity for the detection of portal hypertension in patients with hepatocellular carcinoma. JHEP Rep. 2020 Jul 17;2(5):100147. doi: 10.1016/j.jhepr.2020.100147. eCollection 2020 Oct.
PMID: 32885156
Soret J, Debray D, Fontbrune FS, Kiladjian JJ, Saadoun D, Latour RP, Valla D, Hernandez-Gea V, Hillaire S, Dutheil D, Plessier A, Bureau C, De Raucourt E. Risk factors for vascular liver diseases: Vascular liver diseases: position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver. Clin Res Hepatol Gastroenterol. 2020 Sep;44(4):410-419. doi: 10.1016/j.clinre.2020.03.010. Epub 2020 Jul 7.
PMID: 32651075
Northup PG, Garcia-Pagan JC, Garcia-Tsao G, Intagliata NM, Superina RA, Roberts LN, Lisman T, Valla DC. Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology. 2020 Nov 20. doi: 10.1002/hep.31646. Online ahead of print.
PMID: 33219529
Nery F, Carneiro P, Correia S, Macedo C, Gandara J, Lopes V, Valadares D, Ferreira S, Oliveira J, Teixeira Gomes M, Miranda HP, Rautou PE, Valla D. Systemic inflammation as a risk factor for portal vein thrombosis in cirrhosis: a prospective longitudinal study. Eur J Gastroenterol Hepatol. 2020 Nov 17. doi: 10.1097/MEG.0000000000001982. Online ahead of print.
PMID: 33208682
Wang L, Guo X, Xu X, De Stefano V, Plessier A, Noronha Ferreira C, Qi X. Anticoagulation Favors Thrombus Recanalization and Survival in Patients With Liver Cirrhosis and Portal Vein Thrombosis: Results of a Meta-Analysis. Adv Ther. 2020 Nov 5. doi: 10.1007/s12325-020-01550-4. Online ahead of print.
PMID: 33155180
Kiladjian JJ, Debureaux PE, Plessier A, Soret-Dulphy J, Valla D, Cassinat B, Rautou PE. Benefits of molecular profiling with next-generation sequencing for the diagnosis and prognosis of myeloproliferative neoplasms in splanchnic vein thrombosis. J Hepatol. 2020 Sep 25:S0168-8278(20)30525-0. doi: 10.1016/j.jhep.2020.07.043. Online ahead of print.
PMID: 32988658
Elkrief L, Houssel-Debry P, Ackermann O, Franchi-Abella S, Branchereau S, Valla D, Hillaire S, Dutheil D, Plessier A, Hernandez-Gea V, Bureau C. Portal cavernoma or chronic non cirrhotic extrahepatic portal vein obstruction. Clin Res Hepatol Gastroenterol. 2020 Sep;44(4):491-496. doi: 10.1016/j.clinre.2020.03.016. Epub 2020 Aug 17.
PMID: 32819872
De Gottardi A, Rautou PE, Schouten J, Rubbia-Brandt L, Leebeek F, Trebicka J, Murad SD, Vilgrain V, Hernandez-Gea V, Nery F, Plessier A, Berzigotti A, Bioulac-Sage P, Primignani M, Semela D, Elkrief L, Bedossa P, Valla D, Garcia-Pagan JC; VALDIG group. Porto-sinusoidal vascular disease: proposal and description of a novel entity. Lancet Gastroenterol Hepatol. 2019 May;4(5):399-411.
PMID: 30957754
Elkrief L, Ferrusquia-Acosta J, Payancé A, Moga L, Tellez L, Praktiknjo M, Procopet B, Farcau O, De Lédinghen V, Yuldashev R, Tabchouri N, Barbier L, Dumortier J, Menahem B, Magaz M, Hernández-Gea V, Albillos A, Trebicka J, Spahr L, De Gottardi A, Plessier A, Valla D, Rubbia-Brandt L, Toso C, Bureau C, Garcia-Pagan JC, Rautou PE; for VALDIG, an EASL consortium. Abdominal Surgery in Patients With Idiopathic Noncirrhotic Portal Hypertension: A Multicenter Retrospective Study. Hepatology. 2019 Mar 29.
PMID: 30924941
Payancé A, Plessier A, Valla D, Rautou PE. Angioplasty with stenting for Budd-Chiari syndrome. Lancet Gastroenterol Hepatol. 2019 Sep;4(9):657-659. doi: 10.1016/S2468-1253(19)30224-9.
PMID: 31279648
Hernández-Gea V, De Gottardi A, Leebeek FWG, Rautou PE, Salem R, Garcia-Pagan JC. Current knowledge in pathophysiology and management of Budd-Chiari syndrome and non-cirrhotic non-tumoral splanchnic vein thrombosis. J Hepatol. 2019 Jul;71(1):175-199. doi: 10.1016/j.jhep.2019.02.015.
PMID: 30924941
Téllez L, Rodríguez de Santiago E, Minguez B, Payance A, Clemente A, Baiges A, Morales-Arraez D, La Mura V, Llop E, Garrido E, Garrido-Lestache E, Tasayco S, Bruno O, Prieto R, Montserrat S, Pons M, Olavarría A, Dos L, Valla D, Jesús Del Cerro M, Bañares R, García-Pagán JC, Rautou PE, Albillos A; VALDIG an EASL consortium. Prevalence, features and predictive factors of liver nodules in Fontan surgery patients: The VALDIG Fonliver prospective cohort. J Hepatol. 2019 Nov 11. pii: S0168-8278(19)30668-3.
PMID: 31726116
Payancé A, Plessier A, Valla D, Rautou PE. Angioplasty with stenting for Budd-Chiari syndrome. Lancet Gastroenterol Hepatol. 2019 Sep;4(9):657-659. doi: 10.1016/S2468-1253(19)30224-9.
PMID: 31279648
Elkrief L, Ferrusquia-Acosta J, Payancé A, Moga L, Tellez L, Praktiknjo M, Procopet B, Farcau O, De Lédinghen V, Yuldashev R, Tabchouri N, Barbier L, Dumortier J, Menahem B, Magaz M, Hernández-Gea V, Albillos A, Trebicka J, Spahr L, De Gottardi A, Plessier A, Valla D, Rubbia-Brandt L, Toso C, Bureau C, Garcia-Pagan JC, Rautou PE; for VALDIG, an EASL consortium. Abdominal Surgery in Patients With Idiopathic Noncirrhotic Portal Hypertension: A Multicenter Retrospective Study. Hepatology. 2019 Sep;70(3):911-924
PMID: 30924941
Transplantation hépatique et maladies rares du foie
Dumortier J, Conti F, Scoazec JY. Posttransplant immune-mediated cholangiopathies. Curr Opin Gastroenterol. 2022 Mar 1;38(2):98-103. doi: 10.1097/MOG.0000000000000815.
PMID: 35098931
Montano-Loza AJ, Ronca V, Ebadi M, Hansen BE, Hirschfield G, Elwir S, Alsaed M, Milkiewicz P, Janik MK, Marschall HU, Burza MA, Efe C, Calışkan AR, Harputluoglu M, Kabaçam G, Terrabuio D, de Quadros Onofrio F, Selzner N, Bonder A, Parés A, Llovet L, Akyıldız M, Arikan C, Manns MP, Taubert R, Weber AL, Schiano TD, Haydel B, Czubkowski P, Socha P, Ołdak N, Akamatsu N, Tanaka A, Levy C, Martin EF, Goel A, Sedki M, Jankowska I, Ikegami T, Rodriguez M, Sterneck M, Weiler-Normann C, Schramm C, Donato MF, Lohse A, Andrade RJ, Patwardhan VR, van Hoek B, Biewenga M, Kremer AE, Ueda Y, Deneau M, Pedersen M, Mayo MJ, Floreani A, Burra P, Secchi MF, Beretta-Piccoli BT, Sciveres M, Maggiore G, Jafri SM, Debray D, Girard M, Lacaille F, Lytvyak E, Mason AL, Heneghan M, Oo YH; International Autoimmune Hepatitis Group (IAIHG).
Risk factors and outcomes associated with recurrent autoimmune hepatitis following liver transplantation. J Hepatol. 2022 Feb 7:S0168-8278(22)00067-8. doi: 10.1016/j.jhep.2022.01.022. Online ahead of print.
PMID: 35143897
Kalisvaart M, Chadha R, De Martin E, Alconchel F, Goldaracena N, Keskin O, Liu J, Nasralla D, Mazzola A, Rammohan A, Spiro M, Tanaka T, Campos-Varela I, Victor D, Vinaixa C, Yoon U, Yoon YI, Hessheimer A, Kabacam G, Sapisochin G, Shaker T, Bhangui P, Chan A, Kirchner V. Proceedings of the 26th Annual Virtual Congress of the International Liver Transplantation Society. Transplantation. 2022 Jun 1. doi: 10.1097/TP.0000000000004183. Online ahead of print.
PMID: 35676871
Pollok JM, Tinguely P, Berenguer M, Niemann CU, Raptis DA, Spiro M; ERAS4OLT.org collaborative. Enhanced recovery for liver transplantation: recommendations from the 2022 International Liver Transplantation Society consensus conference. Lancet Gastroenterol Hepatol. 2023 Jan;8(1):81-94. doi: 10.1016/S2468-1253(22)00268-0.
PMID: 36495912
Baumann U, Karam V, Adam R, Fondevila C, Dhawan A, Sokal E, Jacquemin E, Kelly DA, Grabhorn E, Pawlowska J, D’Antiga L, Jara Vega P, Debray D, Polak WG, de Ville de Goyet J, Verkade HJ; European Liver and Intestine Transplant Association (ELITA) and all ELTR contributing centers. Prognosis of Children Undergoing Liver Transplantation: A 30-Year European Study. Pediatrics. 2022 Oct 1;150(4):e2022057424. doi: 10.1542/peds.2022-057424.
PMID: 36111446
Hukkinen M, Wong M, Demir Z, Salem RH, Debray D, Renolleau S, Sissaoui S, Lacaille F, Girard M, Oualha M, Querciagrossa S, Fabre M, Lozach C, Clement R, Lasne D, Borgel D, Capito C, Chardot C. Antithrombin supplementation for prevention of vascular thrombosis after pediatric liver transplantation. J Pediatr Surg. 2022 Nov;57(11):666-675. doi: 10.1016/j.jpedsurg.2022.06.008. Epub 2022 Jul 2.
PMID: 35871859
Laue T, Demir Z, Debray D, Cananzi M, Gaio P, Casotti V, D’Antiga L, Urbonas V, Baumann U. Under-Vaccination in Pediatric Liver Transplant Candidates with Acute and Chronic Liver Disease-A Retrospective Observational Study of the European Reference Network TransplantChild. Children (Basel). 2021 Aug 3;8(8):675. doi: 10.3390/children8080675.
PMID: 34438566
Dumortier J, Besch C, Moga L, Coilly A, Conti F, Corpechot C, Bello AD, Faitot F, Francoz C, Hilleret MN, Houssel-Debry P, Jezequel C, Lavayssière L, Neau-Cransac M, Erard-Poinsot D, de Lédinghen V, Bourlière M, Bureau C, Ganne-Carrié N. NON-INVASIVE DIAGNOSIS AND FOLLOW-UP IN LIVER TRANSPLANTATION. Clin Res Hepatol Gastroenterol. 2021 Jul 28:101774. doi: 10.1016/j.clinre.2021.101774. Online ahead of print.
PMID: 34332131
Lloyd C, Arshad A, Jara P, Burdelski M, Gridelli B, Manzanares J, Colledan M, Jacquemin E, Reding R, Baumann U, Kelly D. Long-term Follow-up of a Randomized Trial of Tacrolimus or Cyclosporine A Microemulsion in Children Post Liver Transplantation. Transplant Direct. 2021 Sep 20;7(10):e765. doi: 10.1097/TXD.0000000000001221. eCollection 2021 Oct.
PMID: 34557582
Recherche fondamentale, translationnelle et pré-clinique
Delaunay JL, Elbahnsi A, Bruneau A, Madry C, Durand-Schneider AM, Stary A, Housset C, Gautheron J, Callebaut I, Aït-Slimane T. Ivacaftor-Mediated Potentiation of ABCB4 Missense Mutations Affecting Critical Motifs of the NBDs: Repositioning Perspectives for Hepatobiliary Diseases. Int J Mol Sci. 2023 Jan 8;24(2):1236. doi: 10.3390/ijms24021236.
PMID: 36674751
Trinh VQ, Lee TF, Lemoinne S, Ray KC, Ybanez MD, Tsuchida T, Carter JK, Agudo J, Brown BD, Akat KM, Friedman SL, Lee YA. Hepatic stellate cells maintain liver homeostasis through paracrine neurotrophin-3 signaling that induces hepatocyte proliferation.
Sci Signal. 2023 May 30;16(787):eadf6696. doi: 10.1126/scisignal.adf6696. Epub 2023 May 30.
PMID: 37253090
Hussein M, Pasqua M, Pereira U, Benzoubir N, Duclos-Vallée JC, Dubart-Kupperschmitt A, Legallais C, Messina A. Microencapsulated Hepatocytes Differentiated from Human Induced Pluripotent Stem Cells: Optimizing 3D Culture for Tissue Engineering Applications.
Cells. 2023 Mar 10;12(6):865. doi: 10.3390/cells12060865.
PMID: 36980206
Housset C. Editorial: The next-generation toolkit for exploring biliary diseases.
Curr Opin Gastroenterol. 2023 Mar 1;39(2):57-58. doi: 10.1097/MOG.0000000000000903.
PMID: 36821451
i L, Bruneau A, El Mourabit H, Guégan J, Folseraas T, Lemoinne S, Karlsen TH, Hoareau B, Morichon R, Gonzalez-Sanchez E, Goumard C, Ratziu V, Charbord P, Gautheron J, Tacke F, Jaffredo T, Cadoret A, Housset C. Portal fibroblasts with mesenchymal stem cell features form a reservoir of proliferative myofibroblasts in liver fibrosis. Hepatology. 2022 Mar 12. doi: 10.1002/hep.32456. Online ahead of print.
PMID: 35278227
Housset C. Editorial: Clinical and pathogenic novelties in cholangiopathies: new treatments and many more to come. Curr Opin Gastroenterol. 2022 Mar 1;38(2):81-82. doi: 10.1097/MOG.0000000000000804.
PMID: 35098929
Bruneau A, Delaunay JL, Durand-Schneider AM, Vauthier V, Ben Saad A, Aoudjehane L, El Mourabit H, Morichon R, Falguières T, Gautheron J, Housset C, Aït-Slimane T. MRCK-Alpha and Its Effector Myosin II Regulatory Light Chain Bind ABCB4 and Regulate Its Membrane Expression. Cells. 2022 Feb 10;11(4):617. doi: 10.3390/cells11040617.
PMID: 35203270
Lotersztajn S, Mallat A. Does CB-1 in hepatic stellate cells contribute to liver fibrosis? J Clin Invest. 2022 Jan 4;132(1):e155413. doi: 10.1172/JCI155413.
PMID: 34981781
Gardin A, Remih K, Gonzales E, Andersson ER, Strnad P. Modern therapeutic approaches to liver-related disorders. J Hepatol. 2022 Jun;76(6):1392-1409. doi: 10.1016/j.jhep.2021.12.015.
PMID: 35589258
Falguières T. ABC Transporters in Human Diseases: Future Directions and Therapeutic Perspectives. Int J Mol Sci. 2022 Apr 12;23(8):4250. doi: 10.3390/ijms23084250.
PMID: 35457067
Messina A, Luce E, Benzoubir N, Pasqua M, Pereira U, Humbert L, Eguether T, Rainteau D, Duclos-Vallée JC, Legallais C, Dubart-Kupperschmitt A. Evidence of Adult Features and Functions of Hepatocytes Differentiated from Human Induced Pluripotent Stem Cells and Self-Organized as Organoids. Cells. 2022 Feb 4;11(3):537. doi: 10.3390/cells11030537.
PMID: 35159346
Mareux E, Lapalus M, Ben Saad A, Zelli R, Lakli M, Riahi Y, Almes M, Banet M, Callebaut I, Decout JL, Falguières T, Jacquemin E, Gonzales E. In Vitro Rescue of the Bile Acid Transport Function of ABCB11 Variants by CFTR Potentiators. Int J Mol Sci. 2022 Sep 15;23(18):10758. doi: 10.3390/ijms231810758.
PMID: 36142670
Housset C. Editorial: Immunity from trigger to therapy in hepatobiliary diseases. Curr Opin Gastroenterol. 2021 Mar 1;37(2):77-78. doi: 10.1097/MOG.0000000000000712.
PMID: 33395091
Gilgenkrantz H, Mallat A, Moreau R, Lotersztajn S. Targeting cell-intrinsic metabolism for anti-fibrogenic therapy. J Hepatol. 2021 Feb 22:S0168-8278(21)00112-4. doi: 10.1016/j.jhep.2021.02.012. Online ahead of print.
PMID: 33631228
Kostallari E, Valainathan S, Biquard L, Shah VH, Rautou PE. Role of extracellular vesicles in liver diseases and their therapeutic potential. Adv Drug Deliv Rev. 2021 Jun 1:S0169-409X(21)00190-3. Online ahead of print.
PMID: 34087329
Amzal R, Thébaut A, Lapalus M, Almes M, Grosse B, Mareux E, Collado-Hilly M, Davit-Spraul A, Bidou L, Namy O, Jacquemin E, Gonzales E. Pharmacological Premature Termination Codon Readthrough of ABCB11 in Bile Salt Export Pump Deficiency: An In Vitro Study. Hepatology. 2021 Apr;73(4):1449-1463.
PMID: 32702170
Piccolo P, Ferriero R, Barbato A, Attanasio S, Monti M, Perna C, Borel F, Annunziata P, Carissimo A, De Cegli R, Quagliata L, Terracciano LM, Housset C, Teckman JH, Mueller C, Brunetti-Pierri N. Up-regulation of miR-34b/c by JNK and FOXO3 protects from liver fibrosis. Proc Natl Acad Sci U S A. 2021 Mar 9;118(10):e2025242118.
PMID: 33649241
Ben Saad A, Vauthier V, Tóth Á, Janaszkiewicz A, Durand-Schneider AM, Bruneau A, Delaunay JL, Lapalus M, Mareux E, Garcin I, Gonzales E, Housset C, Aït-Slimane T, Jacquemin E, Di Meo F, Falguières T. Effect of CFTR correctors on the traffic and the function of intracellularly retained ABCB4 variants. Liver Int. 2021 Jun;41(6):1344-1357. Epub 2021 Mar 25.
PMID: 33650203
Altieri M, Sérée O, Lobbedez T, Segol P, Abergel A, Blaizot X, Boillot O, Boudjema K, Coilly A, Conti F, Chazouillères O, Debette-Gratien M, Dharancy S, Durand F, Duvoux C, Francoz C, Gugenheim J, Hardwigsen J, Houssel-Debry P, Kamar N, Latournerie M, Lebray P, Leroy V, Neau-Cransac M, Pageaux GP, Radenne S, Salamé E, Saliba F, Samuel D, Vanlemmens C, Besch C, Launoy G, Dumortier J. Risk factors of de novo malignancies after liver transplantation: a French national study on 11004 adult patients. Clin Res Hepatol Gastroenterol. 2021 Mar 11;45(4):101514.
PMID: 33714907*
Paillet J, Plantureux C, Lévesque S, Le Naour J, Stoll G, Sauvat A, Caudana P, Tosello Boari J, Bloy N, Lachkar S, Martins I, Opolon P, Checcoli A, Delaune A, Robil N, de la Grange P, Hamroune J, Letourneur F, Autret G, Leung PSC, Gershwin ME, Zhu JS, Kurth MJ, Lekbaby B, Augustin J, Kim Y, Gujar S, Coulouarn C, Fouassier L, Zitvogel L, Piaggio E, Housset C, Soussan P, Maiuri MC, Kroemer G, Pol JG. Autoimmunity affecting the biliary tract fuels the immunosurveillance of cholangiocarcinoma. J Exp Med. 2021 Oct 4;218(10):e20200853. doi: 10.1084/jem.20200853. Epub 2021 Sep 8.
PMID: 34495298
Luce E, Messina A, Duclos-Vallée JC, Dubart-Kupperschmitt A. Advanced Techniques and Awaited Clinical Applications for Human Pluripotent Stem Cell Differentiation into Hepatocytes. Hepatology. 2021 Aug;74(2):1101-1116. doi: 10.1002/hep.31705. Epub 2021 Aug 22.
PMID: 33420753
Bouzbib C, El Mourabit H, Wendum D, Lasnier E, Mouri S, Housset C, Thabut D, Weiss N, Rudler M. ATP-binding cassette transporters expression in rats with cirrhosis and hepatic encephalopathy. Clin Res Hepatol Gastroenterol. 2021 Aug 9:101784. doi: 10.1016/j.clinre.2021.101784. Online ahead of print.
PMID: 34384925
Boul M, Benzoubir N, Messina A, Ghasemi R, Mosbah IB, Duclos-Vallée JC, Dubart-Kupperschmitt A, Le Pioufle B. A versatile microfluidic tool for the 3D culture of HepaRG cells seeded at various stages of differentiation. Sci Rep. 2021 Jul 7;11(1):14075. doi: 10.1038/s41598-021-92011-7.
PMID: 34234159
Ben Saad A, Vauthier V, Lapalus M, Mareux E, Bennana E, Durand-Schneider AM, Bruneau A, Delaunay JL, Gonzales E, Housset C, Aït-Slimane T, Guillonneau F, Jacquemin E, Falguières T. RAB10 Interacts with ABCB4 and Regulates Its Intracellular Traffic. Int J Mol Sci. 2021 Jun 30;22(13):7087. doi: 10.3390/ijms22137087.
PMID: 34209301
Mareux E, Lapalus M, Ben-Saad A, Callebaut I, Falguières T, Gonzales E, Jacquemin E. In vitro functional rescue by ivacaftor of an ABCB11 variant involved in PFIC2 and intrahepatic cholestasis of pregnancy. Orphanet J Rare Dis. 2021 Nov 18;16(1):484. doi: 10.1186/s13023-021-02125-4.
PMID: 34794484
Luce E, Messina A, Caillaud A, Si-Tayeb K, Cariou B, Bur E, Dubart-Kupperschmitt A, Duclos-Vallée JC. [Hepatic organoids: What are the challenges?]. Med Sci (Paris). 2021 Oct;37(10):902-909. doi: 10.1051/medsci/2021119. Epub 2021 Oct 14.
PMID: 34647879
Mareux E, Lapalus M, Amzal R, Almes M, Aït-Slimane T, Delaunay JL, Adnot P, Collado-Hilly M, Davit-Spraul A, Falguières T, Callebaut I, Gonzales E, Jacquemin E. Functional rescue of an ABCB11 mutant by ivacaftor: a new targeted pharmacotherapy approach in bile salt export pump deficiency. Liver Int. 2020 May 20. doi: 10.1111/liv.14518. Online ahead of print.
PMID: 32433800
Vaquero J, Judée F, Vallette M, Decauchy H, Arbelaiz A, Aoudjehane L, Scatton O, Gonzalez-Sanchez E, Merabtene F, Augustin J, Housset C, Dufour T, Fouassier L. Cold-Atmospheric Plasma Induces Tumor Cell Death in Preclinical In Vivo and In Vitro Models of Human Cholangiocarcinoma. Cancers (Basel). 2020 May 19;12(5):E1280. doi: 10.3390/cancers12051280.
PMID: 32438553
Aoudjehane L, Gautheron J, Le Goff W, Goumard C, Gilaizeau J, Nget CS, Savier E, Atif M, Lesnik P, Morichon R, Chrétien Y, Calmus Y, Scatton O, Housset C, Conti F. Novel defatting strategies reduce lipid accumulation in primary human culture models of liver steatosis. Dis Model Mech. 2020 Apr 29;13(4):dmm042663. doi: 10.1242/dmm.042663.
PMID: 32094147
Villemain L, Prigent S, Abou-Lovergne A, Pelletier L, Chiral M, Pontoglio M, Foufelle F, Caruso S, Pineau R, Rebouissou S, Chevet E, Zucman-Rossi J, Combettes L. Sigma 1 Receptor is Overexpressed in Hepatocellular Adenoma: Involvement of ERα and HNF1α. Cancers (Basel). 2020 Aug 7;12(8):2213. doi: 10.3390/cancers12082213.
PMID: 32784704
Amzal R, Thébaut A, Lapalus M, Almes M, Grosse B, Mareux E, Collado-Hilly M, Davit-Spraul A, Bidou L, Namy O, Jacquemin E, Gonzales E. Pharmacological premature termination codon readthrough of ABCB11 in bile salt export pump deficiency: an in vitro study. Hepatology. 2020 Jul 23. doi: 10.1002/hep.31476. Online ahead of print.
PMID: 32702170
Thietart S, Rautou PE. Extracellular vesicles as biomarkers in liver diseases: a clinician’s point of view.
J Hepatol. 2020 Jul 15:S0168-8278(20)30467-0. doi: 10.1016/j.jhep.2020.07.014. Online ahead of print.
PMID: 32682050
Alsafri MS, Charbit-Henrion F, Lacaille F, Bourrat E, Steffann J, Hadj-Rabia S. Novel CLDN1 Deletion Associated with Ichthyosis, Sclerosing Cholangitis and Acquired Alopecia. Acta Derm Venereol. 2020 Jun 11;100(13):adv00173. doi: 10.2340/00015555-3522.
PMID: 32424433
Vauthier V, Ben Saad A, Elie J, Oumata N, Durand-Schneider AM, Bruneau A, Delaunay JL, Housset C, Aït-Slimane T, Meijer L, Falguières T. Structural analogues of roscovitine rescue the intracellular traffic and the function of ER-retained ABCB4 variants in cell models. Sci Rep. 2019 Apr 30
PMID: 31040306
Maladies avec atteintes hépatiques
Dumortier J, Lachaux A, Collardeau-Frachon S, Valette PJ. Hemorrhagic and necrotic adenoma associated with a congenital portosystemic shunt. Dig Liver Dis. 2020 May 17:S1590-8658(20)30182-1. doi: 10.1016/j.dld.2020.04.026. Online ahead of print.
PMID: 32434737
Dana J, Girard M, Debray D. Hepatic manifestations of cystic fibrosis. Curr Opin Gastroenterol. 2020 May;36(3):192-198. doi: 10.1097/MOG.0000000000000624.
PMID: 32097175
Koot BGP, Kelly DA, Hadzic N, Gonzales E, Hierro L, Davenport M, Keil R, Fockens P, Baumann U. Endoscopic Retrograde Cholangiopancreatography in Infants: Availability Under Threat: A Survey on Availability, Need, and Clinical Practice in Europe and Israel. J Pediatr Gastroenterol Nutr. 2020 Aug;71(2):e54-e58. doi: 10.1097/MPG.0000000000002752.
PMID: 32304552
Kyrana E, Rees D, Lacaille F, Fitzpatrick E, Davenport M, Heaton N, Height S, Samyn M, Mavilio F, Brousse V, Suddle A, Chakravorty S, Verma A, Gupte G, Velangi M, Inusa B, Drasar E, Hadzic N, Grammatikopoulos T, Hind J, Deheragoda M, Sellars M, Dhawan A. Clinical management of sickle cell liver disease in children and young adults. Arch Dis Child. 2020 Nov 11:archdischild-2020-319778. doi: 10.1136/archdischild-2020-319778. Online ahead of print.
PMID: 33177052